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Summary 
Sepsis and sepsis-associated multi-organ failure are major challenges for clinicians and 
scientists and are characterized by high patient morbidity and mortality. One factor thought 
to be important in the etiology of systemic inflammatory response syndrome (SIRS) is the 
breakdown of the intestinal barrier resulting in bacterial translocation and subsequent bac-
teremia causing sepsis. Whereas the influence of sepsis on the innate immune system is 
well described, the counter regulatory mechanisms and the impact on adaptive immunity 
are still largely unknown. In this thesis, the influences of gut-derived bacteria on the induc-
tion of systemic adaptive immune responses were investigated.  
The results presented demonstrate that the loss of gut barrier function led to release of vast 
amounts of intestinal bacteria, which rapidly disseminated in the organism. Bacteremia 
caused suppression of adaptive cytotoxic immune responses against subsequent infections 
with viral and bacterial pathogens. This suppression was characterized by impaired expan-
sion of antigen-specific cytotoxic T cells and a lack of antigen-specific cytotoxicity. Inte-
restingly, bacterial translocation from the gut did not necessarily result in suppression of T 
cell responses. If only low amounts of bacteria translocated, bacteria were retained within 
the liver which prevented dissemination of gut-derived bacteria, bacteremia, and subse-
quent immunosuppression. Importantly, the induction of local immunity at peripheral sites 
was not affected by bacteremia, contradicting the current opinion of a general, systemic 
immunosuppression following sepsis. Moreover, bacteremia exclusively inhibited the gen-
eration of subsequent adaptive immune responses, whereas already initiated antigen-
specific CTL responses were further stimulated by systemic bacteria. Although E.coli, 
which was used in this study as a model organism for translocating bacteria, stimulates a 
broad variety of Toll-like receptors (TLRs), suppression was solely dependent on TLR4 
activation. Interestingly, neither TLR4 downstream signaling via MyD88 nor expression of 
the potent suppressive cytokine IL-10 contributed to the observed immunosuppression af-
ter bacteremia. Instead signaling via TRIF and subsequent expression of type I interferons 
(IFNs) were critically involved in E.coli-mediated CTL suppression. 
We could demonstrate that adaptive immune responses towards systemic pathogens were 
generated in the spleen and furthermore, that suppression of systemic CTL responses strict-
ly depended on the presence of bacteria in the spleen. Splenic macrophages and DCs, 
which are crucially involved in the induction of T cell responses as metallophilic marginal 
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zone macrophages (MMMs) efficiently phagocytose blood borne antigens and transfer 
them to cross-presenting DCs (Backer et al., 2010). These cells were impaired in their abil-
ity to induce adaptive immunity to subsequent adenoviral infection after exposure to E.coli. 
These findings underline a central role of splenic macrophages and DCs in immunosup-
pression after sepsis.  
The observed suppression of adaptive immunity was surprising as pathogens are known to 
be potent activators of the innate immune system by stimulation of pattern-recognition 
receptors, such as TLRs. Activation of the innate immune system is an essential prereque-
site for the initiation of effective adaptive immune response (Akira et al., 2006; Iwasaki 
and Medzhitov, 2004). However, in this study we showed that activation of innate immuni-
ty indeed strictly depended on TLR signaling, whereas TLR signaling was dispensable for 
the generation of effective adaptive immune responses. Activation of TLRs led to effective 
induction of innate immunity but also exerts mechanisms, namely secretion of type I IFNs, 
which regulated adaptive immune responses in a paracrine manner. 
Taken together, the findings presented in this study, demonstrate a dual role of TLR signal-
ing. Depending on the anatomical site, dose, and time point of TLR ligand application sys-
temic adaptive immune response are either stimulated or suppressed. Moreover, these data 
may provide further insights for the development of new therapeutic approaches to cir-
cumvent suppression of systemic adaptive immune response in septic patients.  
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Zusammenfassung 
Sepsis und durch Sepsis ausgelöstes multiples Organ Versagen sind eine große Herausfor-
derung für Mediziner und Wissenschaftler und zeichnen sich durch eine hohe Morbidität 
und Sterblichkeit aus. Ein Faktor, der seit langem mit der Ätiologie des systemischen 
inflammtorischen Response Syndrom (SIRS) assoziiert wird, ist der Verlust der Darmbar-
riere, in dessen Folge eine Translokation von Darmbakterien zu einer Sepsis führen kann. 
Obwohl der Einfluss der Sepsis auf das angeborene (innate) Immunsystem  in der Literatur 
hinreichend beschrieben ist, sind die regulierenden Mechanismen des Organismus und die 
Auswirkungen der Sepsis auf das erworbene (adaptive) Immunsystem weitgehend unbe-
kannt. In der vorliegenden Arbeit wurde der Einfluss von aus dem Darm translozierten 
Bakterien auf die Induktion von adaptiven Immunantworten untersucht. 
Die präsentierten Ergebnisse zeigen, dass es durch den Verlust der Darmbarriere zum 
Übertritt von Bakterien kommt, die sich schnell im Organismus verteilen. In Folge dieser 
Bakteriämie wurde die Induktion von adaptiven Immunantworten auf eine nachfolgende 
virale oder bakterielle Infektion unterdrückt. Diese Suppression war gekennzeichnet durch 
eine beeinträchtigte Proliferation Antigen-spezifischer zytotoxischer T Lymphocyten 
(ZTL), so wie durch einen Verlust der Antigen-spezifischen Zytotoxizität der CD8 T Zel-
len. Jedoch führte eine bakterielle Translokation aus dem Darm nicht zwingend zu einer 
Suppression der T Zellen, da die Leber in der Lage war Bakterien zurückzuhalten und da-
mit sowohl eine systemische Verteilung der Bakterien, als auch ein nachfolgende Immun-
suppression zu verhindern. Die Induktion adaptiver, lokaler Immunantworten durch syste-
misch vorhandene Bakterien war nicht beeinträchtigt. Dieser Befund widerspricht der all-
gemeinen Meinung einer generellen Immunparalyse in Folge von Sepsis. Zudem verhin-
dert eine Bakteriämie ausschließlich die Induktion einer adaptiven Immunantwort gegen 
nachfolgende Infektionen, hingegen wurden bereits bestehende ZTL Immunantworten 
durch systemisch vorhandene Bakterien stimuliert. Obwohl E.coli, welches in dieser Studie 
als Modell für translozierende Bakterien verwendet wurde, eine Vielzahl von Toll-like 
Rezeptoren (TLR) stimuliert, war die Suppression ausschließlich von der Aktivierung von 
TLR4 abhängig. Interessanterweise war weder die Signalkaskade über MyD88 noch die 
nachfolgende Expression des immunsuppressiven Zytokins IL-10 an der beobachteten 
Suppression beteiligt. Stattdessen spielten das Adaptormolekül TRIF, sowie die nachfol-
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gende Expression von Typ I Interferonen (IFN) in der durch E.coli hervorgerufenen Im-
munsuppression eine wichtige Rolle. 
Wir konnten zeigen, dass die Induktion adaptiver Immunantworten gegen systemische In-
fektionen in der Milz erfolgte und dass die Suppression systemischer ZTL Antworten nur 
ausgelöst wurde, wenn die Bakterien die Milz erreichten. Metallophile Makrophagen 
(MMM) und dendritische Zellen (DZ) der Milz, sind ursächlich an der Generierung von 
adaptiven T Zell Antworten beteiligt, da die MMM höchst effizient Antigene aus dem Blut 
aufnehmen und diese an kreuzpräsentierende DZ weiterreichen (Backer et al., 2010). Diese 
Zellen waren nicht mehr in der Lage eine adaptive Immunantwort auf eine nachfolgende 
Infektion zu generieren, wenn diese E.coli ausgesetzt wurden. Diese Befunde verdeutli-
chen die zentrale Rolle von DZ und MMM in der Induktion der Immunsuppression nach 
Sepsis. 
Die beobachtete Suppression adaptiver Immunantworten war unerwartet, da Pathogene 
TLR aktivieren und somit das innate Immunsystem stimulieren. Ferner ist die Aktivierung 
des innaten Immunsystems essentiell für das Einleiten einer effektiven adaptiven Immun-
antwort (Akira et al., 2006; Iwasaki and Medzhitov, 2004). Hier konnten wir zeigen, dass 
zwar die Aktivierung des innaten Immunsystems tatsächlich vom TLR-Signal abhängig 
war, für die Generierung einer effektiven, adaptiven Immunantwort hingegen die Aktivie-
rung der TLR nicht vonnöten war. Die Aktivierung von TLR führte auf der einen Seite zur 
Aktivierung des innaten Immunsystems, auf der anderen Seite wurden aber auch Mecha-
nismen ausgelöst, die die adaptive Immunantwort durch Typ I IFN parakrin regulierten.  
Zusammenfassend zeigen die hier präsentierten Ergebnisse eine duale Funktion der TLR-
Signalwirkung. Abhängig von der anatomischen Verteilung, Dosis und des Zeitpunktes der 
Gabe von TLR Liganden, wurde eine systemische Immunantwort entweder stimuliert, oder 
unterdrückt. Darüber hinaus könnten diese Daten weitere Erkenntnisse  für die Entwick-
lung neuer Therapien bieten, um in Zukunft die Suppression des systemisch, adaptiven 
Immunsystems zu verhindern.            
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1 Introduction 
1.1 The immune system 
The immune system (from Latin immunis literally untouched, free) allows organisms to 
fight efficiently against invading and life-threatening pathogens such as viruses, bacteria, 
fungi, and parasites as well as foreign or malignant cells. To defend the body against these 
pathogens multiple mechanisms of immune defense have evolved which are divided into 
two major subdivisions: 
1) The innate immune system is the first line of defense and protects the host by rec-
ognition of pathogenic patterns that are non-self and common to many pathogens.   
  
2) The acquired or adaptive immune system is composed of cells which recognize 
specific antigens and provide elimination of pathogens in the later phase of infec-
tion. Importantly, cells of the adaptive immune system form an immunological 
memory which allows a more rapid response to re-infection with the same patho-
gen. 
1.1.1 The innate immune system 
The elements of the innate immune system include anatomical barriers, secretory mole-
cules, and cellular components. Mechanical anatomical barriers are formed by the skin and 
internal epithelial layers, the movement of the intestines, and the oscillation of broncho-
pulmonary cilia all of which prevents pathogens to enter the organism. Associated with 
these protective surfaces are chemical and biological agents. Lysozym and phospholipase 
which breakdown bacterial cell walls can be found in tears, nasal secretions, and salvia. 
Very small peptides called defensins bear strong antimicrobial activity and cover the sur-
face of the skin, lung, and gastrointestinal tract. Even though these anatomical surface bar-
riers are quiet efficient, they can be broken by mechanical stress thereby allowing patho-
gens to invade the organism. After passing the anatomical barrier, pathogens encounter a 
set of soluble factors and cells that efficiently eliminate invading microorganisms. The 
complement system lyses bacteria and mark them via opsonization for phagocytic cells like 
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macrophages. Cytokines and chemokines activate phagocyting cells, lead them to the site 
of infection and display antibacterial and antiviral effects as well.  
Cells of the innate immune system recognize germs via a variety of highly conserved, 
germ line-encoded pattern recognition receptors (PPRs) that detect components of foreign 
pathogens referred to as pathogen-associated molecular patterns (PAMPs). PRRs are ex-
pressed on the cell surface or in intracellular compartments of many cell types including 
macrophages and dendritic cells (DCs). Different PRRs react with specific PAMPs, acti-
vate specific signaling pathways, and lead to distinct anti-pathogen responses. Most impor-
tantly, stimulation of PRRs leads to activation and maturation of professional antigen pre-
senting cells (APCs) which in turn stimulate adaptive immune responses. The most promi-
nent APCs are DCs, which upon activation by PAMPs, efficiently prime T cells responses 
and thus display the linkage between innate and adaptive immunity (Medzhitov and 
Janeway, 1997). Overall the innate immune system uses a variety of highly efficient im-
mune effectors to combat pathogens. Nevertheless the efficacy of these effectors is limited 
due to the immunopathology they can cause.    
 
1.1.2 The adaptive immune system 
The adaptive immune system minimizes collateral damage by focusing immune defense in 
an antigen-specific manner. The most important effectors of the adaptive immune system 
are T cells, mediating cellular immunity, and B cells, mediating humoral immunity. In con-
trast to the strictly conserved PRRs of the innate immune system, the receptors of adaptive 
immunity, namely the B cell (BCR) and the T cell receptor (TCR), are not encoded in the 
germ line but instead develop during maturation by somatic recombination. Therefore 
every B and T cell carries a unique receptor with one distinct antigen-specificity which 
results in an enormous repertoire of antigens that can be recognized. In addition to cell-
bound BCRs, B cells secrete antibodies, the soluble form of the BCR which bind to the 
respective antigen in its native conformation. Most toxins and extracellular pathogens are 
rapidly neutralized or tracked for phagocytosis by antibodies. In contrast, infected cells are 
recognized and eliminated by antigen-specific T cells. For activation of T cells, the respec-
tive antigenic peptide has to be presented on major histocompatibility molecules (MHC) 
expressed for example by APCs. Upon activation antigen-specific T and B cells undergo 
substantial proliferation which allows rapid and effective clearance of the infection.  
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In contrast to innate immune responses which offer immediate protection, the onset of 
adaptive immune reactions can take up to weeks. For this reason the adaptive immune sys-
tem developed a unique immunological memory which allows immediate and effective 
antigen-specific immune responses upon re-exposure to the cognate pathogen.  
During TCR and BCR development, an enormous variety of antigen-specificity of the 
adaptive immune system is created that is not able to unfailingly discriminate between “in-
fectious non-self“ and “non-infectious self“. Importantly, T and B cells that recognize self 
are eliminated during development. However, some cells recognizing self might survive 
that can lead to detrimental consequences for the host such as autoimmune diseases. To 
prevent the host from damage of its own misguided immune system the adaptive immune 
system is precisely tuned by the innate immune system. This ensures that APCs trigger 
adaptive immunity only in the presence of PAMPs. 
 
1.2 Pattern recognition receptors 
To avoid detrimental activity of the immune system to the organism it is obligatory to dis-
criminate between self, infectious non-self, and innocuous non-self which was proposed by 
Charles Janeway 20 years ago (Janeway, 1989, 1992; Janeway and Medzhitov, 2002; 
Medzhitov and Janeway, 2002). Cells of the innate immune system recognize germs via a 
variety of highly conserved, germ line-encoded PPRs that have evolved to detect con-
served structures of pathogens referred to as PAMPs. To fulfill this function, PPRs have 
several important properties. First, they only recognize PAMPs which are unique to micro-
bes. Second, they sense a broad variety of pathogens so that a limited number of germ line-
encoded receptors detect nearly all infections. Third, PAMPs are essential for the pathogen 
to survive and therefore are not easily eliminated due to mutations (Akira et al., 2006; 
Medzhitov and Janeway, 2002; Palm and Medzhitov, 2009). Beside the secreted form of 
PRRs like the mannan-binding protein or the C-reactive protein, membrane-bound PRRs 
are divided into two main classes:                
1) Transmembrane PRRs which recognize PAMPs in the extracellular space or in 
 phagosomes and endosomes.  
2) Cytosolic PRRs sensing PAMPs in the cytosol. 
    Introduction 
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1.2.1 Transmembrane PRR 
The best characterized members of the transmembrane PRR family are the family of Toll-
like receptors (TLRs). Originally the protein “Toll” was discovered by the group of Chris-
tiane Nüsslein-Volhard in 1985 and was shown to be essential in the embryogenesis of 
Drosophila melanogaster (Anderson et al., 1985). Later, TLRs where shown to play a cru-
cial role in the induction of immune responses in Drosophila as well as in mammals 
(Lemaitre et al., 1996). TLRs sense infection trough the recognition of PAMPs and induce 
innate and adaptive immune responses (Iwasaki and Medzhitov, 2004; Pasare and 
Medzhitov, 2004). Furthermore, TLRs have been shown to be sufficient to control adaptive 
immunity leading to an adequate adaptive immune response. Another member of the 
transmembrane PRRs is Dectin-1 which recognizes β-glucans from fungal pathogens such 
as Candida albicans (Brown and Gordon, 2001). Analogous to TLRs, Dectin-1 stimulation 
alone has been shown to be sufficient to induce adaptive immune responses (LeibundGut-
Landmann et al., 2007). In contrast to TLRs Dectin-1, is reported to enhance phagocytosis 
and influence phagosome trafficking (Herre et al., 2004). 
1.2.2 Cytosolic PRR 
The cytosolic PRRs can be divided into two subclasses based on their mechanism of acti-
vation. PRR as the nucleotide-binding oligomerization domain (Nod) containing Nod1 and 
Nod2, the retinoic acid-inducible gene I (RIG-I)-like helicases and the interferon stimulator 
DNA (ISD) sensor can be activated directly by their respective ligands (Meylan et al., 
2006; Takeuchi and Akira, 2007). Nod1 and Nod2 sense bacterial infections by detection 
of peptidoglycan fragments in the cytosol. In contrast, RIG-I recognizes RNA viruses in 
most cell types and activates an antiviral innate immune response which is characterized 
by type I interferon (IFN) production. The ISD sensor is activated by cytosolic DNA de-
rived from DNA viruses and retroviruses. Both, RIG-I as well as ISD activation, has been 
shown to be sufficient for the induction of T cell and antibody responses. The second class 
contains members of the (Nod)-like receptors (NLR) family that is involved in the forma-
tion and activation of multimeric protein complexes, namely the inflammasomes. They 
control the activation of caspase-1 and furthermore the secretion of caspase-1-dependent 
cytokines like IL-1β upon stimulation.  
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1.2.3 Toll-like receptors 
The expression pattern of TLRs is quiet conserved among the mammals (Rast et al., 2006). 
Currently, 13 mammalian TLRs , expressed on the cell surface or in the endoplasmatic 
reticulum and endosomal compartments have been identified (Baccala et al., 2007). Cell 
surface TLRs 1, 2, 4, 5, 6, and 11 sense lipids, lipoproteins, or peptidoglycans from bacte-
ria, fungi, or protozoa. Intracellular TLRs 3, 7, 8 and 9 detect bacterial and viral nucleic 
acids. The ligands for TLRs 10, 12, and 13 have not yet been identified. TLR10 is ex-
pressed in humans but not mice, TLR8 is not functional in mice, and TLRs 11, 12, and 13 
are exclusively expressed in mice but not humans.  
TLRs are type I membrane glycoproteins with a trimodular structure. They consist of an 
extracellular domain containing leucine-rich-repeat motifs that promote the detection of 
PAMPs and a cytoplasmic domain which allows downstream signaling and subsequent 
expression of proinflammatory cytokines and chemokines. TLRs are expressed on a broad 
range of immune cells such as DCs, macrophages, and B cells. These TLRs serve to sense 
bacteria, funghi, protozoa, and viruses and therefore play an important role in initiation of 
appropriate immune responses.  
1.2.4 Toll-like receptor ligands 
TLRs recognize a broad variety of PAMPs, also referred to as TLR ligands (TLR-L) (Fig-
ure 1.1). The cell wall of gram positive and gram negative bacteria are sensed by TLR1, 
TLR2, TLR4, and TLR6. The most potent immunostimulant is a lipid portion of lipopoly-
saccharide (LPS) mainly released from gram negative bacteria such as Escherichia coli. 
LPS associates with LPS binding protein (LBP) and binds to CD14. LPS is then transferred 
to MD-2 which associates with the extracellular portion of TLR4. The cell wall of gram 
positive bacteria such as Staphylococcus aureus contains only very low amounts of LPS. 
Instead TLRs are stimulated by lipoteichoic acid (LTA), lipoproteins, and pepdidoglycan 
(PG) derived from the cell wall of gram positive bacteria. TLR2 plays a major role in de-
tecting gram positive bacteria and interacts physically with TLR1 and TLR6. Another 
component of many bacteria, falgellin is sensed by TLR5. Flagellin is a constituent of bac-
terial flagella, the motility apparatus used by many microbial pathogens. Furthermore bac-
terial DNA can be recognized by TLR9 present in the endosome. TLR9 senses the unme-
thylated CpG oligonucleotide which is abundant in bacterial genomes.  
    Introduction 
6 
 
Viruses are recognized by endosomal TLRs, namely TLR3, TLR7, TLR8, and TLR9. 
DNA viruses such as herpes simplex virus 1 (HSV-1) or murine cytomegalovirus (MCMV) 
contain genomes that are rich in CpG-DNA motives and therefore activate TLR9. TLR7 
and TLR8 are highly homologous, are both expressed in the endosomal membrane and 
sense single-stranded RNA (ssRNA) of both viral and host origin. Double stranded RNA 
(dsRNA) is generated during viral replication of ssRNA viruses and is recognized by 
TLR3. Mostly viral stimulation of TLRs leads to profound expression of type I interferons 
and proinflammatory cytokines.  
 
1.2.5 Toll-like receptor signaling 
Stimulation of TLRs by their respective ligands triggers potent activation of signaling cas-
cades leading to the induction of genes involved in host defense. TLRs signal via the cy-
toplasmic domain which is homologous to the cytoplasmic region of the IL-1 receptor, 
known as the Toll/IL-1 receptor (TIR) domain. Upon stimulation, TLRs dimerize and un-
dergo conformational changes which arrange recruitment of TIR-domain-containing adap-
tor molecules to the TIR domain of the TLR. Five TIR-domain containing adaptors are 
known to be involved in TLR signaling namely MyD88, MyD88-adaptor-like (MAL, also 
known as TIRAP), TIR-domain-containing adaptor protein inducing IFN-β (TRIF, also 
known as TICAM1), TRIF-related adaptor molecule (TRAM) and sterile α-and armadillo-
motif-containing protein (SARM) (O'Neill and Bowie, 2007; Oshiumi et al., 2003a). The 
diversity of responses to distinct TLR ligands partially refers to selective usage of these 
adaptor molecules. In most TLRs except TLR3 downstream signaling is mediated by the 
TIR domain-containing adaptor molecule MyD88 (Akira et al., 2006). Upon binding of a 
ligand to its respective TLR, MyD88 is recruited and in turn recruits a variety of IL-1 re-
ceptor-associated kinases (IRAKs) which leads to robust activation of NF-κB and subse-
quent expression of inflammatory cytokines such as Interleukin-6 (IL-6), IL-12 or tumor 
necrosis factor (TNF). The second TLR adaptor molecule is the TIR-domain-containing 
adapter-inducing interferon-β (TRIF) which initiates downstream signaling of TLR3 and 
TLR4. TRIF is known to control the TLR4-induced MyD88-independent pathway and is 
the only adaptor associated with TLR3. Activation of TRIF is associated with profound 
expression of interferons (IFN) through the activation of interferon regulatory factor 3 
(IRF3) (Fitzgerald et al., 2003b; McWhirter et al., 2004). Furthermore, in contrast to 
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MyD88, TRIF can directly activate NF-κB and IRF3 which activates the interferon-β tran-
scription. TLR4 is unique among the TLRs because it is the only TLR that is able to recruit 
both adaptor molecules, MyD88 and TRIF.  MAL is required for signaling by TLR2 and 
TLR4, serving as a bridge to recruit MyD88. TRAM is the most restricted adaptor in TLR 
signaling as it exclusively interacts with TRIF in the TLR4 pathway(Fitzgerald et al., 
2003b; Oshiumi et al., 2003b; Yamamoto et al., 2003b). TRAM is membrane-associated 
and acts analogous to MAL in MyD88 signaling as a bridging adaptor for TRIF (Hornung 
et al., 2006). SRAM, in contrast to the other four adaptor molecules, is a negative regulator 
of NF-κB and IRF activation (Carty et al., 2006). SRAM expression was shown to specifi-
cally inhibit TRIF-dependent gene induction without affecting the MyD88-dependent 
pathway of TLR signaling. 
In general TLR signaling is mediated by selective use of different adaptor molecule com-
binations by different TLRs. Activation of TLRs by their respective ligands leads to dis-
tinct and characteristic intracellular signaling and expression of proinflammatory cytokines 
by induction of NF-κB. Additionally, several TLR signaling pathways lead to the expres-
sion of type I interferons by activation of TRIF. 
 
Figure 1.1   Toll-like receptors and their ligands. 
Toll-like receptors (TLRs) are expressed on the cell surface or in intracellular compartments and 
recognize distinct conserved pathogen-associated molecular patterns (PAMPs), which are also 
known as TLR ligands. Upon TLR stimulation, intracellular adaptor molecules are recruited which 
initiate intracellular signaling pathways that activate NFκB- and IRF-dependent target genes result-
ing in the expression of proinflammatory cytokines and type I interferons (IFN). 
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1.3 Activation of T cells by APCs 
Naïve T cells constantly circulate within the lymphatic tissue where they encounter their 
specific antigen presented by APCs on MHC molecules. Two classes of MHC molecules 
exist, namely MHC class I and MHC class II (Germain, 1994). MHC class I molecules are 
expressed on all nucleated cells and predominantly present endogenous peptides to anti-
gen-specific T cells expressing the CD8 co-receptor. Therefore presentation of cytosolic 
peptides on MHC class I is a crucial mechanism in viral defense as activated cytotoxic 
CD8 T cells are able to sense and lyse infected cells. In contrast, MHC class II molecules 
are almost exclusively expressed on APCs such as DCs, macrophages, and B cells. For 
presentation, exogenous antigen is internalized by APCs and upon processing in lysosomes 
antigen-derived peptides are loaded on MHC class II. After transfer of the MHC class II 
molecule to the cell surface the antigenic peptide is presented to antigen-specific CD4-
expressing T cells (Wolf and Ploegh, 1995).  
Beside the recognition of the specific antigen presented on MHC molecules, which is also 
known as signal 1, T cell activation requires additional signals. Signal 2 involves co-
stimulation by molecules such as CD80/86 provided on APC side which bind to CD28 on 
the T cell and trigger survival of T cells as well as secretion of cytokines (Boise et al., 
1995; Carreno and Collins, 2002) like IL-2, a cytokine supporting the proliferation of T 
cells (Cantrell and Smith, 1984). Signal 3 is provided by cytokines such as IL-12 or type I 
IFNs which are secreted by matured APCs upon TLR stimulation or CD40 ligation 
(Curtsinger et al., 1999; Trinchieri et al., 2003). CD40 expressed by matured DCs interacts 
with CD40L, which is expressed on activated CD4 T helper cells. In that way, CD4 T cell 
help licenses the DC to initiate an efficient cytotoxic CD8 T cell response and stimulate 
generation of functional CD8 T cell memory.  
Differentiation of naïve T cells into effector T cells strictly dependents on theses 3 signals 
(Curtsinger et al., 2003a; Curtsinger et al., 2003b). Moreover CD4 T cells develop into T 
helper cells (TH), which are subdivided into TH1, TH2 and TH17 cells (Moser and Murphy, 
2000). TH1 cells are crucial for the protection against intracellular pathogens as they pro-
duce IFN upon stimulation. TH2 are directed against extracellular pathogens and induce 
the production of IL-4 (Moser and Murphy, 2000). TH17 cells are characterized by the 
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secretion of IL-17 and are involved in the clearance of extracellular pathogens (Bettelli et 
al., 2008). 
Antigen-specific naïve T cells exist at very low frequencies in the host. However, upon 
activation they undergo massive expansion. This expansion phase lasts for five to eight 
days and CD8 T cell numbers may increase by > 10,000-fold (Badovinac and Harty, 2002; 
Butz and Bevan, 1998; Doherty, 1998). When cytotoxic T cells recognize infected cells 
they eliminate these cells by the release of cytotoxic agents such as granzymes, perforins 
and granulysin. A second way to kill target cells is the induction of apoptosis by stimula-
tion of the FAS receptor by FAS ligand on the T cell. In the contraction phase after clear-
ance of pathogens and infected cells, 90%-95% of the effector T cells undergo elimination 
(Sprent and Tough, 2001).  
1.4 The immunopathogenesis of sepsis 
The term sepsis describes a complex clinical syndrome that results from a harmful or da-
maging host response to infection. In Germany about 150,000 cases of sepsis are reported 
each year with an overall mortality of 30-50% (Brunkhorst, 2006).  
The host immune response during sepsis can be separated into distinct but overlapping 
phases. The initial response in sepsis, referred to as the systemic inflammatory response 
syndrome (SIRS), is characterized by release of a number of inflammatory mediators in-
cluding early response cytokines such as TNF, IL-1β, IL-6, IL-12, leukocyte-active che-
mokines, adhesion molecules, and leukotrienes (Dinarello, 2000; Levy et al., 2003). This 
initiation of substantial cytokine release is due to a systemic activation of immune res-
ponses by high levels of PAMPS and/or damaged host tissue, which in turn leads to over-
stimulation of immune cells. This so-called “cytokine storm” is accompanied by a dysregu-
lation of the complement system characterized by excessive production of the complement 
factor C5a. The effects of C5a contribute to immunoparalysis, multi-organ failure, and 
imbalances in the coagulation system (Huber-Lang et al., 2001; Huber-Lang et al., 2002; 
Laudes et al., 2002). This cytokine storm, the massive release of complement, as well as 
the loss of coagulation can end up in multi organ dysfunction syndrome (MODS) and death 
(Rittirsch et al., 2008). The initial hyper-inflammatory phase is followed by counterregula-
tion of the immune system characterized by the profound release of inhibitory molecules 
including anti-inflammatory cytokines such as IL-10, transforming growth factor-beta 
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(TGF-β), suppressors of pathogen recognition signaling cascades, immunomodulatory ei-
cosanoids and hormones (van der Poll and van Deventer, 1999). This counter-regulatory 
phase is referred to as the compensatory anti-inflammatory response syndrome (CARS) 
(Bone, 1996a, b). SIRS and CARS overlap considerably and the overall immune status of 
patients depends on which response is dominant (Lyn-Kew and Standiford, 2008).    
Moreover multiple immune cells are affected in sepsis and thus contribute to CARS. 
Changes in macrophages and monocyte function in sepsis includes the down-regulation of 
inflammatory cytokines such as IL-6 and TNF as well as the incapacity to release nitric 
oxide which illustrates the lack of respiratory burst (Goya et al., 1992; Munoz et al., 1991; 
Reddy et al., 2001). Splenic DCs undergo rapid apoptosis upon systemic endotoxin admin-
istration in mice. Similarly, there is a prolonged loss of DCs up to 15 days post induction 
of abdominal sepsis in both lung and spleen (Hotchkiss et al., 2002; Wen et al., 2008). Like 
macrophages and DCs, various lymphocyte populations are influenced by sepsis and likely 
contribute to the immunosuppressive effect of sepsis. DCs not undergoing apoptosis pro-
duce less IL-12 after exposure to high doses of endotoxin. Sepsis results in a substantial 
drop in the number of circulating B cells and CD4 T cells whereas no alterations in the 
CD8 T cell population could be observed (Hotchkiss et al., 2001). The late phase of sepsis 
is characterized by the expression of anti-inflammatory cytokines. IL-10 is one of the most 
potent anti-inflammatory cytokines which mediates leukocyte deactivation during sepsis. 
Upon stimulation with PAMPs, it is produced by many cells of the adaptive immune sys-
tem such as T cells and B cells as well by cells of the innate immune system, for instance 
DCs, macrophages, mast cells, NK cells, eosinophiles and neutrophils (Siewe et al., 2006; 
Zhang et al., 2009). During infection, IL-10 inhibits the activity of Th1 cells, NK cells, and 
macrophages, which all contribute to an effective clearance of pathogens but tissue damage 
as well (Couper et al., 2008). When exposed to IL-10, DCs fail to induce a potent Th1 im-
mune response. Furthermore, IL-10 inhibits the production of cytokines such as IL-2, TNF, 
and IL-5 as well as the proliferation of CD4 T cells and activation of T cells in the pres-
ence of IL-10 is described to result in anergy. In contrast, IL-10 has stimulatory effects on 
CD8 T cells and induces their recruitment, cytotoxic activity, and proliferation.  (Couper et 
al., 2008; Moore et al., 2001; Saraiva and O'Garra, 2010).  
Overall, the pathomechanisms of sepsis are very complex, dynamic, and not fully unders-
tood. Due to the fact that not a single key mediator causes sepsis, trials to neutralize such a 
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factor mostly failed and during the past years the mortality and rates of sepsis have not 
decreased (Dombrovskiy et al., 2007a, b). 
 
1.5 Bacterial translocation from the gut 
The human gut harbors approximately 1x10
14
 bacteria; tenfold more than the number of 
eukaryotic cells in an adult’s body (Gill et al., 2006). Therefore, the gut represents a criti-
cal barrier between this huge reservoir of endotoxins and the entire body. Breakdown or 
overwhelming of this barrier results in the egress of bacteria and endotoxins with subse-
quent development of sepsis, initiation of a cytokine-mediated SIRS, MODS, and death. 
This process was termed “bacterial translocation” and describes the so-called “gut origin of 
sepsis hypothesis” (Berg and Garlington, 1979; Fraenkel, 1891; Nieuwenhuijzen et al., 
1996a; Pastores et al., 1996). Therefore the gut may be an important factor of multiple or-
gans failure and elucidates the absence of a discreet focus of infection in most patients with 
delayed SIRS and MODS.  
Although there is growing evidence that bacterial translocation from the intestine is a nor-
mal phenomenon occurring in homeostasis, detrimental breakdown of the gut barrier func-
tion is described in several circumstances (Garside et al., 2004; Spahn and Kucharzik, 
2004). Factors that influence bacterial translocation are believed to act on the homeostatic 
equilibrium between luminal organisms and the gut barrier (Wells, 1990) such as intestinal 
obstruction (Deitch, 1989; Sedman et al., 1994), jaundice (Deitch et al., 1990b; Sakrak et 
al., 2003), inflammatory bowel disease (MacFie et al., 2006; Takesue et al., 2002), ischae-
mia-reperfusion injury (Deitch, 2002), and several traumas including burn (Magnotti and 
Deitch, 2005) and stroke (Caso et al., 2009).  
Even though bacterial translocation from the gastrointestinal tract is a well described phe-
nomenon, the predominant route of translocating bacteria is controversially discussed 
(Berg, 1985, 1990, 1992, 1995; Deitch and Berg, 1987a; Deitch et al., 1990a). With respect 
to the anatomy of the gut two distinct routes are involved in dissemination of gut-derived 
bacteria: first, translocation via the mesenteric lymph nodes (mLNs) and/or second, vascu-
lar dissemination via the gut draining blood vessels. During their passage to the mLNs, 
most bacteria may be killed by the host´s defense system such as macrophages. The spread 
of bacteria beyond the mLN is supposed to go along the cysterna chilli and via the thoracic 
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duct draining in the left subclavin vein. Draining of bacteria via the vascular route allocates 
them along the vena mesenterica superior or vena mesenterica inferior and the portal vein 
into the liver. The route of bacterial dissemination is supposed to depend on the mechan-
ism that promotes bacterial translocation. According to this, penetration of the intestinal 
epithelium and subsequent intracellular passage leads to translocation via the lymphatic 
vessels, whereas disruption of the tight junctions would enable the extracellular passage of 
gut-derived bacteria resulting in their vascular distribution (Berg, 1995).  
1.6 Role of the liver and Kupffer cells in host defense 
The liver is the largest organ in the abdomen, weighing approximately 1,5 kg in healthy 
adult humans. It serves a variety of functions such as synthesis and turnover of plasma pro-
teins, the storage and metabolism of carbohydrates, the production of bile, and the detox-
ification of potentially dangerous chemicals. In addition, the liver plays a major role in 
clearing systemic bacterial infections (North, 1974). The clearance of bacteria as well as 
endotoxins is generally ascribed to fixed tissue macrophages namely Kupffer cells, which 
line the liver sinusoids and constitute the largest compartment of tissue macrophages 
present in the body (Klein et al., 1994). Nutrient rich venous blood is drained from the in-
testine via the portal vein which terminates in the liver and about 75% of hepatic blood is 
derived from this vein (Parikh et al., 2010). Kupffer cells are predominantly found in the 
periportal area and represent the first macrophage population to get in contact with bacteria 
and endotoxin derived from the gastrointestinal tract (Fox et al., 1987).    
The rapid elimination of bacteria taken up by the liver is dependent on the complex inte-
raction of Kupffer cells and microbicidal neutrophils, which immigrate rapidly in response 
to infection (Gregory et al., 2002; Gregory and Wing, 2002). Beside their phagocytic ca-
pacity, Kupffer cells are shown to bind bacteria extracellular by interaction of lectins on 
Kupffer cells and carbohydrate residues expressed by bacteria (Ofek and Sharon, 1988; 
Perry and Ofek, 1984). Bacteria bound to Kupffer cells are eliminated by immigrating neu-
trophils. Additionally, platelets have been shown to contribute to the inflammatory 
processes and participate on the fight against infection (Klinger and Jelkmann, 2002). Ac-
tivation of platelets by TLR4 ligands leads to their binding to adherent neutrophils in the 
sinusoids which in turn leads to robust neutrophil activation and rapid formation of “neu-
trophils extracellular traps” (NETs) which are web-like structures of DNA that trap and kill 
bacteria (Brinkmann et al., 2004; Clark et al., 2007). Overall the majority of bacteria and 
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endotoxin coming from the gut or the circulation is cleared within the liver by Kupffer 
cells with the aid of neutrophils and platelets.  
 
1.7 The spleen 
The spleen is a secondary lymphoid organ that harbors about one fourth of the body´s lym-
phocytes and half of body´s monocytes. It fulfills two important functions in the body. 
First, the spleen has an important filter function for the blood and second, initiates immune 
responses to blood-borne antigens (Balogh et al., 2004; Cesta, 2006; Nolte et al., 2002). 
Splenectomized patients are more susceptible to infections with encapsulated pathogens 
including streptococci, pneumococci and meningococci (Cadili and de Gara, 2008).  
The unique architecture of the spleen consists of two functionally and morphologically 
distinct compartments: the white pulp and the red pulp which are separated in space by the 
marginal zone (Figure 1.2 A).  
 
Figure 1.2   Structure of the white pulp of the spleen    
(A) The central ateriol [A] is sheathed by the white pulp (WP). The WP consists of T cell areas (T) 
and B cell zones [B] both of which are separated from the red pulp (RP) by the marginal zone 
(MZ).  
(B) The outer ring of the marginal zone adjacent to the red pulp consists of marginal zone macro-
phages (MZMs), reticular fibroblasts, dendritic cells, and marginal zone B cells (MZ B cells). The 
inner ring mainly consists of marginal zone metallophilic macrophages (MMMs) and lymphocytes. 
The marginal sinus, that separates the outer and the inner ring, is lined by endothelial cells.  
Adapted from (Mebius and Kraal, 2005). 
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1.7.1 The red pulp 
The red pulp represents the non-lymphoid compartment of the spleen and functions as a 
blood filter that removes cellular debris and senescent red blood cells. Furthermore the red 
pulp stores erythrocytes, platelets, and iron. Arterial blood arrives into cords in the red 
pulp, a three dimensional meshwork that is build up by fibroblasts, reticular fibers, and 
associated macrophages. It forms an open blood system without an endothelial lining 
(Groom et al., 1991). Due to their stiffened membranes, senescent erythrocytes are unable 
to pass the splenic cords into the venous sinuses (Bratosin et al., 1998; Mebius and Kraal, 
2005) and are actively phagocytosed by macrophages in the red pulp. These macrophages 
then recycle the iron of aging erythrocytes (Knutson and Wessling-Resnick, 2003).  
 
1.7.2 The white pulp 
The white pulp represents the lymphoid compartment and closely resembles the structure 
of a lymph node (Nolte et al., 2000). It is organized by lymphoid sheaths with T and B cell 
zones. In the T-cell zone, also known as periarteriolar lympohoid sheaths (PALS), T cells 
interact with DCs and passing B cells. In the B-cell zone activated B cells undergo clonal 
expansion which leads to isotype switching and somatic hypermutation. The integrity of 
the T- and B-cell zone is maintained by selective recruitment of T and B cells to their re-
spective site by chemokines. CC chemokine ligand 19 (CCL19) and CCL21 attracts T cells 
and DCs to the T-cell zone, whereas CXCL13 is required for B cell recruitment to the B-
cell zone (Ansel et al., 2000; Forster et al., 1999; Gunn et al., 1999).  
 
1.7.3 The marginal zone 
The marginal zone surrounds the white pulp and is involved in the induction of innate as 
well as adaptive immune responses. All cells that migrate from the red pulp into the white 
pulp have to pass the marginal zone. This is believed to be an active process in which G-
protein coupled receptors, chemokines, and cell-cell interaction are essentially involved 
(Cyster and Goodnow, 1995; Johnston and Butcher, 2002; Kraal and Mebius, 2006). Be-
sides being a transit area, the marginal zone contains a large number of resident cells that 
not only have unique properties but also seem to depend on each other for their localization 
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thereby establishing and maintaining the integrity of the marginal zone (Mebius and Kraal, 
2005). Adjacent to the red pulp, the marginal zone forms a thicker outer ring which is 
composed of sinus lining endothelial cells, marginal zone macrophages (MZMs), reticular 
fibroblasts, DCs, and marginal zone B cells. The thinner, inner ring is build up by sinus 
lining endothelial cells separating the marginal sinus from the MZMs and metallophilic 
marginal zone macrophages (MMMs). MZMs and MMMs differ in their expression of 
surface molecules. MZMs express SIGNR1, a C-type lectin, and a type I scavenger recep-
tor, namely macrophage receptor with collagenous structure (MARCO). MMMs are cha-
racterized by the expression of the sialic acid-binding immunoglobulin-like lectin-1 (Sig-
lec-1, CD169). These surface molecules are closely associated with recognition and bind-
ing of pathogens. SIGNR1 on MZMs mediates binding to polysaccharides on pathogens 
such as Streptococcus pneumoniae or Mycobacterium tuberculosis and Siglec-1 on MMMs 
has been shown to serve as a phagocytic receptor for sialylated pathogens such as Neisse-
ria meningitides (Jones et al., 2003; Kang et al., 2004; Lanoue et al., 2004). The other im-
portant receptor MARCO, present at the surface of MZMs and in less extend on MMMs, 
can recognize many pathogens including Escherichia coli and Staphylococcus aureus 
(Elomaa et al., 1995). These receptors enable macrophages in the marginal zone so sense, 
trap, and eliminate blood-borne bacteria. Importantly, our group recently could show that 
MMMs efficiently capture adenoviruses and exclusively transfer antigen to CD8+ splenic 
DCs, thereby essentially contributing to initiation of adaptive immune responses in the 
spleen (Backer et al., 2010). 
1.7.4 Dendritic cells in the spleen    
DCs are professional APCs that most efficiently prime T cell responses. Spleen-resident 
DCs can be divided into different subsets based on their localization, expression of pheno-
typic markers, and function (Heath et al., 2004). DCs positive for CD8 are predominantly 
found in the T cell zone and outer marginal zone of the spleen and are further characterized 
by the expression of DEC205 (CD205) (Idoyaga et al., 2009). The subpopulation of 
DEC205+ DCs present in the marginal zone is specialized in cross-presentation of antigens 
and activation as well as tolerization of CD8+, cytotoxic T lymphocytes (Belz et al., 2005; 
den Haan et al., 2000; Schulz and Reis e Sousa, 2002). CD8- DCIR2+ DCs are mainly lo-
calized in the marginal zone and are specialized in the activation of CD4+ T lymphocytes 
by presentation of antigens on MHCII molecules (Dudziak et al., 2007). Upon activation 
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by microbial products, all DC subsets present in the marginal zone migrate to the T cell 
areas of the spleen where they interact with antigen-specific T cells (De Smedt et al., 1996)       
 
1.8 Type I interferons 
Type I interferon (IFN) was discovered by Isaacs and Lindenmann in 1957 and originally 
described as an “activity” that was secreted by virus-infected cells that protects other cells 
from infection (Isaacs and Lindenmann, 1957). The name IFNs describes their ability to 
stimulate the synthesis of a large set of antiviral gene products which “interfere” with viral 
replication and spread (Katze et al., 2002). In mammals the type I IFN genes form a large 
multigene family comprising the species α, β, κ, ω, and τ (Pestka et al., 2004b). During 
viral and bacterial infection, IFN-α and IFN-β are the main synthesized type I IFNs. A sin-
gle IFN-β gene is found in most mammals, but the IFN-α family is formed by 14 functional 
genes in mice. However, the biological significance of having many IFN-α genes is not yet 
clear. The production of type I IFN is triggered upon stimulation with viral and bacterial 
PAMPs in almost all cell types including macrophages, DC subsets, natural killer cells 
(NK cells), and T cells (Bogdan et al., 2004). PPR stimulation results in a secretion of im-
mediate-early type I IFNs. This fast expression of type I IFNs is promoted by interferon 
regulatory factor 3 (IRF3) which is expressed in probably all cells (Fitzgerald et al., 
2003a). IRF3-induced type I IFN is rapid and results in low amounts of IFN-α/β that in-
itiates an amplification loop by autocrine and paracrine stimulation of the type I IFN recep-
tor (IFNAR). Both, IFN-α and IFN-β, signal via the IFNAR complex which comprises two 
subunits, IFNAR1 and IFNAR2 (Stark et al., 1998). These two chains are permanently 
associated with members of the Janus protein tyrosine kinase family, specifically with the 
tyrosine kinase 2 (TYK2) and Janus kinase 1 (JAK1). Upon IFN binding to IFNAR, janus 
kinases phosphorylate the receptor and Signal Transducers and Activator of Transcription 
(STATs). Phosphorylation initiates signal transduction in association with IRF9 which 
binds to the IFN-stimulated response element (ISRE) and leads to subsequent expression of 
interferon-regulated genes like iNOS, CD80, CD86, or IRF 7 (Noppert et al., 2007). In 
turn, IRF7 binds to the IRF binding site (IRFBDS) and induces delayed but profound pro-
duction of INFα (Figure 1.3). Besides their well known antiviral properties, type I IFNs 
enhance DC maturation and promote the activation as well as differentiation of CD8 T 
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cells by providing signal 3 (Curtsinger et al., 2005; Luft et al., 1998; Montoya et al., 2002). 
Thus, type I IFNs are crucially involved in linking innate and adaptive immune responses 
(Uematsu and Akira, 2007). 
 
Figure 1.3   LPS-induced production of type I IFNs 
In cells that not constitutively express little or no IRF7, amounts of the protein are increased by an 
amplification loop. Rapid signal transduction through TLR4 causes IRF3 activation, IFN-β synthe-
sis, and signal transduction through the IFNAR. IFNAR signal transduction includes phosphoryla-
tion of IRF9 and subsequent IRF7 expression because the protein is encoded by an IFN-inducible 
gene (ISRE). Activation of newly synthesized IRF7 by tank-binding kinase (TBK1) leads to in-
creased expression of IFN-β and many IFN-α genes. 
Adapted from (Decker et al., 2005) and (Mahieu and Libert, 2007) 
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2 Aim of the thesis 
 
Sepsis is currently the 10
th
 leading cause of death and accounts for significant healthcare 
expenditures in the developed world. As the gut represents a large reservoir for endotoxins, 
it is assumed that the loss of gut barrier function results in bacterial translocation and sub-
sequent sepsis. The pathophysiology of sepsis is inherently complex and research efforts in 
the field of sepsis have largely focused on the innate immune system, whereas the influ-
ence on adaptive immunity remains largely unknown.  
The aim of this thesis was to analyze the influence of gut-derived bacteria on the induction 
of systemic immune responses. We were particularly interested in the following questions:     
 
 Does bacterial translocation influence the induction of adaptive immunity? 
 
 What is the liver’s role in preventing the dissemination of gut-derived bacteria? 
 
 Which role does the spleen play in the suppression of adaptive immunity? Which 
splenic cell types mediate immunity? Are they affected in their function to generate 
immunity by exposure to E.coli? 
 
 Is activation of TLR and its downstream signaling involved in mediating immune 
suppression?  
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3 Material and Methods 
3.1 Materials 
3.1.1 General laboratory equipment 
Autoclave Belimed, Köln 
Balances U4100-OD2.2 and MC BA 100 (Sartorius, Göttingen)  
Beakers 5 ml, 10 ml, 25 ml, 50 ml, 100 ml, 150 ml, 250 ml, 500 ml 
(Schott, Mainz) 
Centrifuges Multifuge3 S-R, Biofuge fresco, Biofuge pico (Heraeus, 
Braunschweig) 
Counting Chamber Neubauer (Brand, Wertheim) 
Digital camera CCD-1300 (Vosskuehler, Osnabrück) 
Erlenmeyer flasks 50 ml, 100 ml, 250 ml, 500 ml (Schott, Mainz) 
Flow cytometers FACSCalibur, CantoII, LSRII (BD Biosciences, Heidel-
berg) 
Freezers (-20°C) Liebherr, Biberach 
Freezers (-80°C) Hera freeze (Heraeus, Braunschweig) 
Heating block ThermoStat plus (Eppendorf, Hamburg) 
Ice machine Icematic (Scotsman, Frimont Bettolinc, Pogliano, Italy) 
Incubators HERAcell (Heraeus, Braunschweig) 
IVIS200 Xenogen, San Francisco, USA 
Magnet stirrer IKA Laboratory Equipment, Staufen 
Measuring cylinders 50 ml, 100 ml, 250 ml, 500 ml, 1l (Schott, Mainz) 
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Microscopes IX71 and CKX31 (Olympus, Hamburg) 
Epifluorescence microscope Edipse TE 2000 (Ni
-/-
n, 
Düsseldorf) 
Microwave Panasonic, Wiesbaden 
pH-meter pH 523 (Wissenschaftlich-Technische Werkstätten, Weil-
heim) 
Pipette-Boy Pipetus (Hirschmann Labortechnik, Eberstadt) 
Pipettes Gilson, Heidelberg and Eppendorf, Hamburg 
Preparation Instruments Labotec, Göttingen 
Refrigerators (+4°C) Bosch, Stuttgart and Liebherr, Biberach 
Sieves, steel University Bonn, Department “Feinmechanik” 
Sonificator UW2070/Sonoplus (Bandeln electronic, Berlin) 
Spectrophotometers Ultrospec 3100 UV/VIS (Amersham Pharmacia, Freiburg); 
NanoDrop™ ND 1000 (NanoDrop Products, Wilmington, 
USA) 
Threaded bottles 100 ml, 250 ml, 500 ml, 1l, 2l (Schott, Mainz) 
Ultra-pure water system NANOpure Diamond, Barnstead (Werner, Reinstwasser-
systeme, Leverkusen) 
Waterbath TW8 (Julabo, Seelbach) 
Workbench, sterile HERAsafe (Heraeus, Hanau)  
 
3.1.2 Software 
Endnote X1 Thomson ISI ResearchSoft, USA 
FACS Diva V6.1.1 BD Biosciences, Heidelberg 
Flowjo V8.8.4 Tree star, Inc., USA 
Illustrator CS4 Adobe, USA 
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Living Image 2.50 (IVIS) Xenogen, USA 
Microsoft Office 2008 Microsoft, USA 
Photoshop CS4 Adobe, USA 
Prism 4 for Macintosh  GraphPad Software, USA 
 
3.1.3 Consumables 
Cover slides 21x46mm (Marienfeld, Lauda-Königshofen) 
Cryo vials VWR International, Darmstadt 
Cryomolds VWR International, Darmstadt 
FACS tubes polystyrene, 12/75 mm (Sarstedt, Nümbrecht) 
Injection needles 27G (grey), 25G (orange), 20G (yellow) (BD Microlance, 
Heidelberg) 
33G (Fine science tools, Heidelberg) 
Inoculation loops  10µl (Greiner bio-one, Solingen) 
Gloves DermaClean™ Ansell, Red Bank New Jersey, USA 
Microtiter plates 96-well, round and flat bottom (Greiner bio-one, Solingen) 
Parafilm Parafilm “M” (American National Can TM, Greenwich, 
USA) 
Pasteur pipettes 150 mm and 230 mm (Roth, Karlsruhe) 
Petri dishes 10 cm (Greiner bio-one, Solingen) 
Pipette tips 10 µl, 200 µl, 1000 µl (Greiner bio-one, Solingen) 
Plastic Pipettes 5 ml, 10 ml, 25 ml (Sarstedt, Nümbrecht) 
Polyamide tissue “Gaze” (Labomedic, Bonn) 
Polypropylene tubes sterile, 15 ml and 50 ml (Greiner bio-one, Solingen) 
Reaction tubes 0.5 ml, 1.5 ml, 2 ml (Eppendorf, Hamburg) 
Scalpel Feather (Osaka, Japan) 
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Sterile filter 0.2 µm (Schleicher & Schuell) 
Syringes 2 ml, 5 ml, 10 ml, 20 ml BD Discardit
TM
 (BD Bioscience, 
Heidelberg) 
Tissue culture plates 6-, 12-, 24-, 48-, 96-well (TPP, St. Louis, USA or Sarstedt, 
Nümbrecht) 
Tuberculin syringes Omnifix-F (Braun, Melsungen) 
 
3.1.4 Chemicals and reagents 
Ampicillin sodium salt Sigma Aldrich, München 
Bovine serum albumin (BSA) Roth, Karlsruhe 
Brain Heart Infusion Broth Roth, Karlsruhe 
CFSE Molecular Probes, Leiden, Netherlandes 
Columbia Blood Agar Base Oxoid, Wesel 
Dimethylsulfoxide (DMSO) Merck, Darmstadt 
Disodium hydrogen phosphate (Na2HPO4)  Merck, Darmstadt 
DOTAP Roth, Karsruhe 
Ethanol, absolute Merck, Darmstadt 
Ethylene diamine tetraacetic acid (EDTA) Sigma Aldrich, München 
Fetal calf serum (FCS) PAA, Cölbe 
Glycerol (C3H8O3) Roth, Karlsruhe 
Heparin Ratiopharm, Ulm 
Hoechst 33258 Sigma Aldrich, München 
Hoechst 33342 Molecular Probes, Leiden, Netherlands 
Isoflurane DeltaSelect, Pfullingen 
LB-medium (Luria/Miller) Roth, Karlsruhe 
Luciferin Caliper Lifesciences, Rüsselsheim 
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MacConkey Agar Roth, Karlsruhe 
Natural silk 5-0 Catgut, Markneukirchen 
Natural silk 4-0 Ethicon, Norderstedt 
Ovalbumin (OVA), grade V Sigma Aldrich, München 
Paraformaldehyde (PFA) Fluca, Buchs 
Phosphate buffered saline (PBS) Biochrom, Berlin 
Phosphate buffered saline (PBS) solution Sigma Aldrich, München 
RPMI 1640 medium Sigma Aldrich, München 
Sodium azide (NaN3) Sigma Aldrich, München 
Sodium bicarbonate (Na2HCO3) Sigma Aldrich, München 
Sodium chloride, 0.9%  B. Braun, Melsungen 
Sodium hydroxide (NaOH) Merck, Darmstadt 
Sucrose Roth, Karlsruhe 
Tachocomb® Nycomed, Konstanz 
Tissue-Tek O.C.T™ Sakura, Netherlands 
Trisodium citrate (Na3C6H5O7) Sigma Aldrich, München 
Trypane blue (0.4%) Lonza, Köln 
Trypsin/EDTA Lonza, Köln 
Triton X-100 Sigma Aldrich, München 
 
3.1.5 Buffers, media and solutions 
FCS (fetal calf serum) 
FCS was heat-inactivated at 56°C for 30 min and stored à 50 ml aliquots at -20°C. 
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PBS (phosphate buffered saline) 
1xPBS was adjusted to pH 7.4, aliquoted à 500 ml, autoclaved and stored at 4°C. 
 
0.5 M EDTA  
186.1g EDTA and 20g NaOH were dissolved in 1000 ml ultra-pure water and the pH was 
adjusted to 7.8 – 8.0. The solution was autoclaved and stored at room temperature. 
 
FACS buffer 
1x PBS containing 1% (v/v) FCS and 0.1% (v/v) NaN3. Stored at room temperature. 
 
4% (w/v) PFA solution 
8 g PFA was dissolved in 200 ml 1xPBS by gradual heating. The pH was adjusted to 7.4 
and aliquots were stored at -20°C. 
 
30% (w/v) sucrose solution 
15 g sucrose were dissolved in 50 ml 1xPBS, freshly prepared. 
 
50 mM luciferin solution 
1 vial of luciferin (1g) was dissolved in 70 ml sterile PBS to obtain a 50 mM stock solution 
(14mg/ml). Aliquots á 2 ml were stored at -20°C. 
 
Türk´s solution 
10% (v/v) acetic acid in 0,4% trypane blue. Stored at room temperature 
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3.1.6 TLR ligands 
CpG-rich oligonucleotides (ODN) were purchased from TIB MolBiol, Berlin. Lyophilized 
CpG ODN was dissolved in sterile PBS at a concentration of 1nmol/µl (= 6.4 µg/µl) by 
incubation at 37°C for 30 min. Dissolved CpG was stored at 4°C. 
ODN Sequence Type Reference 
CpG-1668 TCC ATG ACG TTC CTG ATG CT CpG-B (Krieg et al., 1995) 
    
polyI:C was ordered from Sigma-Aldrich, München, and dissolved in 0.9% NaCl at a con-
centration of 1 µg/µl. Aliquots were stored at -20°C. 
Substance Description Reference 
polyI:C (C10H10N4NaO7P)x • (C9H11N3NaO7P)x (Ranjith-Kumar et 
al., 2007) 
 
Lipopolysaccharide (LPS) was purchased from Invivogen, dissolved in 0.9% NaCL at a 
concentration of 1µg/µl. Aliquots were stored at -20°C 
Substance Description Reference 
LPS ultrapure E.coli O111:B4 (Poltorak et al., 
1998) 
 
3.1.7  Peptides 
Peptides were obtained from Pineda, Invitrogen, or Sigma-Aldrich. They were dissolved as 
20 mM stock solutions in DMSO and stored at -20°C. 
Peptides  MHC haplotype Amino acid sequence 
OVA254-267 (S8L) H-2k
b 
SIINFEKL  
Influenza peptides H-2k
b 
ASNENMETM and SSLENFRAYV 
HSV peptide H-2k
b
 SSIEFARL 
   
    Material and Methods 
26 
 
 
3.1.8 Antibodies 
Immunohistology antibodies 
The following antibodies were used in immunohistology of spleens. Anti-Siglec-1 antibo-
dy was kindly provided by Prof. Kraal, VU University Medical Center, Amsterdam, De-
partment of Molecular Cell Biology and Immunology  
Antigen Species Clone Source  Conjugate 
Biotin   Invitrogen Streptavidin-AlexaFluor®488 
Biotin   Invitrogen Streptavidin-AlexaFluor®647 
CD11c Hamster N418 eBioscience Biotin 
GFP Goat Polyclonal Gene Tex Biotin 
Siglec-1 Rat SER-4 Prof. Kraal, Ams-
terdam 
AlexaFluor®488 
Rat Goat  Invitrogen AlexaFluor®647 
Hamster Goat  Jackson             
ImmunoResearch 
 
MxA  M143 Prof. Haller, Frei-
burg 
 
 
Fluorochrome conjugated antibodies used in FACS  
The following antibodies were purchased from eBioscience or BD Biosciences (if not oth-
erwise stated) for flow cytometric analysis of murine molecules expressed at the cell sur-
face or intracellularly. All antibodies were labeled with a fluorochrome (FITC, PE, PE-
Cy7, PerCP-Cy5.5, APC, Al647, APC-Cy7, Pacific Blue, Al405) and employed at pre-
viously determined concentrations. 
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Antigen Isotype  Clone Annotation 
CD11b rat IgG2b,  M1/70 = Mac-1, integrin M chain 
CD11c hamster IgG N418 = integrin X chain 
CD16/32 rat IgG2b,  2.4G2 = anti FcᵞR III + II 
CD4 rat IgG2b,  GK1.5  
CD8a rat IgG2a, 53-6.7 = Ly-2 
F4/80 rat IgG2a, BM8  
Gr-1 rat IgG2a, RB6-8C5  
S8L/H-2K
b
 
Pentamers 
  purchased from Proimmune 
  
3.1.9 Viruses and bacteria 
Viruses and bacteria used in this study were kindly provided by other scientists. 
 
Pathogen Description Source (Reference) 
AdOVA E1 and E3 deleted recombinant 
adenoviral vector expressing 
the full length OVA protein 
under the CMV promoter 
Dr. Andreas Unter-
gasser; Prof. Dr. Ulrike 
Protzer 
AdLOG E1 and E3 deleted recombinant 
adenoviral vector expressing 
luciferase, OVA-derived pep-
tide SIINFEKL, and GFP 
Prof. Dr. Thomas 
Tüting  
(Schweichel et al., 
2006) 
E.coli K12 laboratory strain Institute stock 
E.coli lux Recombinant Escherichia coli 
expressing luxABCD genec-
luster 
Dr. Ulrich Dobrinth 
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HSV-1 Wild type Herpes simplex vi-
rus type 1 
Dr. Christoph Coch; 
Nico Busch 
Influenza virus Wild type Influenza A 
PR8/H1N1 virus 
Dr. Christoph Coch; 
Nico Busch 
LmOVA  Recombinant Listeria monocy-
togenes expressing the full 
length OVA protein 
Prof. Dr. Klaus Pfeffer; 
Dr. Stefanie Scheu 
(Pope et al., 2001) 
Listeria monocytogenes EGD strain Prof. Trinad Chackra-
borty 
MCMV-OVA Mouse cytomegalovirus ex-
pressing the full length OVA 
protein 
Prof. Dr. Percy Knolle 
(Sacher et al., 2008) 
 
pHrodo™ E.coli Bioparticles® conjugate was purchased from Molecular Probes™, Invi-
trogen, Karlsruhe. E.coli Bioparticles® get visible upon phagocytosis, as they are conju-
gated to pHrodo™, a dye that is sensitive to acidic pH. Preparation of E.coli Bioparticles® 
was performed according to the manufacturer’s instructions. Briefly 2 ml provided “uptake 
buffer” were added to the lyophilized product. The solution was briefly vortexed and soni-
cated for 10 min. until homogenous dispension. 
 
3.1.10 Mouse strains 
C57BL/6(N) or C57BL/6(J) wild type strains (H-2K
b
) were purchased from Charles River, 
Sulzfeld, or Janvier, France. Mice were bred under pathogen free conditions and in accor-
dance to institutional animal guidelines in the animal facility (HET, House of Experimental 
Therapy) of the University of Bonn. Following knock out (
-/-
) or transgenic animals back-
crossed on C57BL/6 were used: 
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Strain Description Source (Reference) 
CD11c-DTX
 
DC-specific expression of the diph-
theria toxin receptor 
Steffen Jung 
(Jung et al., 2002) 
CD14 
-/- 
deficient in CD14 PD Dr. Georg 
Baumgarten 
(Haziot et al., 1996) 
IFNAR 
-/-
 deficient in the type I IFN receptor 
 
Prof. Dr. Rainer 
Zawatzky 
(van den Broek et 
al., 1995) 
IL-10 GFP  Reporter mice expressing GFP under 
the IL-10 promoter 
Prof. Dr. Hermann 
Wagner  
(Bouabe et al., 
2008) 
IL-10 
-/-
 deficient in IL-10 Prof. Dr. Achim 
Hörauf  
(Kuhn et al., 1993) 
IRF3/7 
-/-
 deficient in IRF3 and IRF7 Prof. Dr. Hermann 
Wagner 
 
IRF7 
-/-
 deficient in IRF7 Prof. Dr. Thomas 
Decker; Prof. Dr. 
Mathias Müller 
(Honda et al., 2005) 
MXA
 
regained expression of MXA protein 
by back-crossing   
PD. Dr. Jörg Wen-
zel 
(Wenzel et al., 
2005b) 
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MyD88 
-/-
 deficient in MyD88 Prof. Dr. Hermann 
Wagner 
(Adachi et al., 
1998) 
TLR2 
-/-
 deficient in TLR2 
Prof. Dr. Hermann 
Wagner 
(Takeuchi et al., 
1999) 
TLR4 
-/-
 deficient in TLR4 Prof. Dr. Hermann 
Wagner 
(Hoshino et al., 
1999) 
TLR9 
-/-
 deficient in TLR9 Prof. Dr. Hermann 
Wagner 
(Hemmi et al., 
2000) 
TNFRI/II deficient in TNF receptor I and II Dr. Horst 
Bluethtmann 
(Pfeffer et al., 1993) 
TRIF 
-/-
 deficient in TRIF Prof. Dr. Hermann 
Wagner 
(Yamamoto et al., 
2003a) 
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3.2 Methods 
3.2.1 Experimental treatment of mice  
Pathogens and other reagents were adjusted in 0.9% NaCl or PBS for experimental injec-
tion of mice. Intravenous (i.v.) and intraperitoneal (i.p.) injections were performed with a 
volume of 200 µl, intraportal (i.po.) injections with a volume of 50 µl. 
 
3.2.1.1 Infection with viruses 
Mice were infected i.v. with 5x10
9
 virus particles of different recombinant adenoviruses  
Mice were infected i.v. with 1x10
4
 PFU Herpes simplex virus type 1 and 1x10
5
 or 1x10
6
 
PFU Influenza A PR8/H1N1 virus.  
 
3.2.1.2 Infection with recombinant Listeria monocytogenes   
Recombinant Listeria monocytogenes expressing OVA (LmOVA) were cultured overnight 
in Brain Heart Infusion Broth shaking at 37°C. Colony forming units (CFU) of LmOVA 
were quantified by McFarland standard. The OD was measured at 600 nm and CFU/ml 
was calculated and the indicated number of bacteria was injected i.v. in 200µl PBS. 
 
3.2.1.3 Infection with E.coli 
Recombinant Escherichia coli expressing the lux operon (E.coli lux) or wild type E.coli 
were cultured for four hours in Luria-Bertani broth containing 20 mg/l Ampicillin. Colony 
forming units (CFU) of E.coli were quantified by McFarland standard. The OD was meas-
ured at 600 nm and CFU/ml was calculated and the indicated number of bacteria was in-
jected i.v. in 200µl PBS 
 
3.2.1.4 Immunization with OVA-coupled DEC205, Siglec-1 and anti- CD40 
Mice received 3 µg OVA-coupled anti-DEC205 or anti-Siglec-1 in combination with 20 
µg anti-CD40 antibody intravenously 
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3.2.1.5 Colon ascendens stent peritonitis (CASP) 
By usage of a scalpel the cannula of a peripheral venous catheter with a diameter of 16G is 
engraved all around at about 2 mm above the tip of the cannula. This cannula is then used 
as a stent which is transplanted into the colon ascendens. After anesthesia of mice with 2% 
Isofluorane and disinfection of the skin with 70% ethanol the abdominal skin and subse-
quent the peritoneum is opened with scissors. The cecum, the colon ascendens and the ter-
minal ileum are carefully laid open and placed on top of the abdominal wall. Now the peri-
pheral venous catheter is introduced into the colon ascendens, the indentation of the cannu-
la is fixed with silk at the intestinal wall and the needle is retracted. The peripheral venous 
catheter is cropped at 1 mm above the serosa and a small drop of gut content is released 
through the stent by gently pressing the cecum. Next the gut is placed back into its anatom-
ical correct position and peritoneum, and skin is sutured.     
  
3.2.1.6 Splenectomy 
Mice were anesthetized with Isofluorane and underwent laparotomy. The spleen was ex-
posed, the ateria splenica was ligated with silk and divided between the spleen and the liga-
tion. After careful removal of the pancreatic tissue a loop of silk is drawn over the spleen 
and posterior the vena splenica is ligated by tighten the loop. The spleen is removed, peri-
toneum, and skin is sutured. 
 
3.2.1.7 Injection of E.coli into the portal vein 
Herewith mice underwent laparotomy and the portal vein was exposed. E.coli was injected 
in a volume of 50µl with a 33 gauge needle into the portal vein and homeostasis was 
achieved pressing a small piece of TachoComb® on the site of injection.  
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3.2.2 Microbiological methods 
3.2.2.1 Determination of bacterial load 
A single cell suspension was prepared from organs by pressing the organs through a sterile 
sieve (mesh size 250 µm). Cell suspension of liver was resuspended in 40 ml PBS, spleen 
and lung were resuspended in 10 ml PBS and mesenteric lymph nodes in 5 ml PBS. 100 µl 
of the cell suspension are plated on selective MacConkey Agar and after 24 h incubation at 
37°C CFU are calculated per organ or per g tissue respectively.   
 
3.2.2.2 Listeria in vitro killing assay by macrophages 
Analysis was performed with the help of Dr. Zeinab Abdullah. Single cell suspension was 
prepared from the spleen of mice injected with UV killed E. coli or PBS by passing 
through cell strainer. Cell suspension was plated in 12  ml of antibiotic free medium 
(RPMI + 10% FCS ) in 10 cm plates for 2 hrs at 37 °C  followed by removal of non adhe-
rent cells by using warm PBS. Adherent cells (macrophages and DCs) were harvested by 
trypsinization. Cells concentration was adjusted to 2x10
6
 cells/ml in RPMI medium and 
250 µl of cell suspension was plated in 48 well plates. Listeria monocytogenes was har-
vested at the log phase by centrifugation at 4000 rpm for 10 min at RT. The pellet washed 
twice with PBS and resuspended in PBS  
OD600 measured and CFU was adjusted to 2x10
7 
CFU/ ml in antibiotic free medium. Me-
dium was aspirated from the cells and 250 µl of the Listeria was added per well and plates 
incubated at 37°C with rotation for 30 min.. A sample of the injected Listeria was cultured 
to control the exact infection dose. After 30 min of incubation cells were washed twice 
with PBS containing 100µg/ml gentamycin to eliminate extracellular bacteria and cells 
were then incubated in 250µl medium (RPMI + 10% FCS+ 50µg/ml gentamycin). Follow-
ing 30, 60, 120 and 240 min after infection, wells were washed twice with PBS (no antibi-
otic) and 150µl of 0.1% triton X (in H2O) were added per well in order to lyse cells. After 
5 min incubation on ice cells lysates were scraped and resuspended thoroughly and five 
serial dilutions of 1: 10 in PBS were prepared. 100µl of the last three dilutions were plated 
on BHI agar plate and incubated 24 h at 37°C followed by determination of the CFU. 
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3.2.3 Flow cytometric analysis (FACS) 
Flow cytometry (fluorescence activated cell sorting, FACS) was used to examine the ex-
pression of different surface molecules and to determine the generation of endogenous 
OVA-specific CD8 T cells by S8L/H-2K
b
 pentamer staining. Data were acquired using a 
FACS Canto II and subsequently analyzed using the FlowJo software.  
 
3.2.3.1 Surface staining of molecules 
Cells were transferred into a 96-well round bottom plate for antibody staining for flow cy-
tometric analysis (approximately 1x10
6
 cells/well) and washed once in FACS buffer. The 
staining was performed in a volume of 50 µl per sample. A mastermix was prepared con-
taining the desired antibodies and anti-CD16/CD32 (blocking of FcR, “Fc block”). Upon 
centrifugation for 3 minutes at 486 x g, cells were resuspended in 50 µl of the mastermix 
and incubated for 20 minutes on ice protected from light. Cells were washed twice in 
FACS buffer and afterwards analyzed by flow cytometry. Hoechst-33258 (1 µg/ml) was 
added to cells shortly before acquisition to exclude dead cells from analysis.  
 
3.2.3.2 S8L/H-2Kb specific pentamer staining 
The generation of endogenous OVA-specific CD8 T cells was determined in spleens of 
mice five days post AdOVA or AdLOG infection using S8L/H2-K
b
 pentamers. The stain-
ing was conducted on a 96-well round bottom plate. Isolated splenocytes were washed 
once in FACS buffer and centrifuged for 3 minutes at 486 x g. Cells were resuspended in 
30 µl FACS buffer containing 5 µl S8L/H-2K
b
 pentamers as well as anti-CD16/CD32 and 
were incubated for 20 minutes at room temperature (light-protected). Afterwards, 20 µl of 
a CD8a antibody was directly added (without centrifugation), which had been diluted in 
FACS buffer. Cells were incubated for further 20 minutes on ice and washed twice in 
FACS buffer before flow cytometric analysis. Hoechst-33258 (1 µg/ml) was added to the 
cells immediately before data acquisition to discriminate between viable and dead cells. 
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3.2.4 Analysis of antigen-specific cytotoxic CD8 T cells  
(in vivo cytotoxicity assay) 
Cytotoxic activity of endogenous antigen-specific CD8 T cells was measured in spleens 
five days post pathogen infection by performing an in vivo cytotoxicity assay (Feuerer et 
al., 2003). Briefly, splenocytes from syngeneic donor mice were divided into two fractions. 
One fraction was pulsed with 1 µM of the specific H-2K
b
 peptides SIINFEKL (OVA), 
ASNENMETM/SSLENFRAYV (Influenza virus), or SSIEFARL (HSV-1 virus) for 20 
minutes at 37°C. Subsequently, peptide-loaded cells were labeled with 1 µM of CFSE by 
incubation for 15 minutes at 37°C (CFSE
high
, target cells). The second fraction was not 
pulsed with peptide and labeled with 0.1 µM CFSE (CFSE
low
, reference cells). Upon labe-
ling, cells were washed extensively and counted. Both populations were mixed in a 1:1 
ratio (CFSE
high
/ CFSE
low
) and 1x10
7
 cells were injected i.v. into recipient mice. Spleens 
were removed four hours later and homogenized by passing through a metal sieve. After 
centrifugation for 10 minutes at 486 x g, splenocytes were resuspended in 5 ml 
MACS buffer. Lysis of peptide-loaded cells was measured by flow cytometric analysis. 
Unimmunized naive mice served as a control. The percentage of specific lysis was calcu-
lated using the following formula: 
% specific cytotoxicity = 100 – [(CFSEhigh/CFSElow)sample / (CFSE
high
/CFSE
low
)control] x100  
 
3.2.5 Histology  
3.2.5.1 Histological analysis of MxA expression 
Sections and staining was kindly performed by Jörg Wenzel, Department of Dermatology 
university of Bonn. In short, MxA labeling was performed on paraffin-embedded tissue 
sections (4 mm). Sections were incubated with anti-MxA-antibody (dilution 1 : 100) over-
night at room temperature after heat antigen retrieval. Secondary labeling was performed 
using the LSAB2 kit (DAKO) (Wenzel et al., 2005a). 
3.2.5.2 Immunohistology of the spleen 
After excision spleens were fixated for 30 min. in 1% PFA and transferred into PBS con-
taining 30% (w/v) sucrose. After spleens had sunken to the bottom of the tubes they were 
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shortly washed with PBS to remove excess sucrose. After careful removal of moisture 
spleen were embedded in fresh O.C.T.™ medium and frozen at -80°C.  
Sectioning and staining were performed on the same day in order to keep background fluo-
rescence low. Spleens were cut into sections of 7 µm and were blocked in 5% (v/v) mouse 
serum in PBS for 5 min. at room temperature. For staining, all antibodies were diluted in 
2% (v/v) mouse serum in PBS. All antibodies were used in previously determined concen-
trations. Between different staining steps, sections were thoroughly washed with PBS. Fol-
lowing incubation for 45 min. with anti-SER-4 and anti-CD11c, sections were stained with 
anti-rat antibody and anti-hamster antibody for 30 min.. After blocking for 15 min. in 20% 
(v/v) rat serum in PBS, sections were incubated for 45 min. with biotinylated anti-GFP and 
for 30 min. with Streptavidin-AlexaFluor®488 conjugate. Nuclei were stained by incuba-
tion of sections with 1 µg/ml DAPI for 10 min.. 
3.2.6 In vivo imaging of bioluminescence 
Mice were analyzed at indicated time points after injection of recombinant AdLOG imme-
diately before measurement of bioluminescence using the real-time IVIS Imaging System, 
mice were injected i.p. with 200 µl luciferin solution. Mice infected with E.coli lux were 
analyzed without injection of luciferin. Analysis was performed under inhalational anes-
thesia with isoflurane. Data were acquired using the Living Image 2.50 software. 
3.2.7 Determination of cell number 
The cell suspension was diluted 1:10 or 1:100 in 0.04% trypane blue to discriminate be-
tween live and dead cells. 10 µl of this suspension was applied to a Neubauer counting 
chamber and living cells were counted in all four large squares. The cell count was calcu-
lated using the following formula: 
Cell number/ml = counted viable cells/4 x dilution x 10
4
 
3.2.8 Statistics 
Results are depicted as mean +/- standard error of the mean (SEM). Statistical significance 
was calculated by an unpaired two-tailed Student’s t test using the Prism software. 
p values of 0.01 to 0.05 were considered as significant (*), p values of 0.001 to 0.01 as 
highly significant (**) and p of <0.001 as extremely significant (***). 
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4 Results 
4.1 Bacterial translocation and its impact on adaptive immune 
responses 
Toll-like receptors (TLR) enable the vertebrate´s immune system to recognize structurally 
conserved molecules derived from pathogens. TLR stimulation by their respective ligands 
leads to activation of the immune system and generally results in immunity (Janeway and 
Medzhitov, 2002). Therefore, locally administered TLR ligands, such as complete 
Freund´s adjuvant, are commonly used as immunopotentiator. However, we and other 
groups have shown that TLR ligands administered systemically induce immunoregulatory 
processes, which result in suppression of antigen-specific immune responses (Mellor et al., 
2005; Wingender et al., 2006). 
The human gut harbors approximately 1x10
14
 bacteria; tenfold more than the number of 
eukaryotic cells in an adult’s body. Therefore, the gut represents a critical barrier between 
this huge reservoir of endotoxins and the entire body. The gut barrier becomes leaky under 
certain conditions, for example in inflammatory bowl diseases (IBD) or as a complication 
occurring after abdominal surgery. Subsequent inflammation leads to the breakdown of the 
gut barrier. As a consequence endotoxins as well as bacteria are released into the periphery 
resulting in sepsis.  
Since it is known that sepsis is a common complication of abdominal surgery we investi-
gated in the present study if circulating bacteria might have analogous effects on the gener-
ation of murine adaptive immune responses.  
4.1.1 Dissemination of E.coli lux after CASP 
As a common animal sepsis model we used the colon ascendens stent peritonitis (CASP) 
technique. In this model a stent is placed colon ascendens in direction to colon transver-
sum, which leads to a subsequent release of the gut content into the peritoneum. Sham 
treated mice underwent laparotomy and the gut was touched with cotton swabs.  
At first we determined the distribution of bacteria in C57BL/6 wild type mice after CASP. 
Besides the classic microbiological techniques, such as determination of colony forming 
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units per organ, we assessed the distribution of bacteria by in vivo imaging of biolumines-
cent luciferase expression at different time points after CASP using the in vivo imaging 
system (IVIS). Mice were fed with luciferase expressing E. coli (E.coli lux) one hour prior 
to gut manipulation. The distribution of bacteria was assessed by in vivo imaging of biolu-
minescent luciferase expression at different time points after CASP using the in vivo imag-
ing system (IVIS).  
 
 
 
Figure 4.1   Distribution of E.coli lux after CASP  
1x1011 E.coli lux were given orally per gavage to wild type C57BL/6 mice one hour before CASP 
procedure. (A) Bacterial distribution in mice was analyzed at indicated time points by in vivo imag-
ing of bioluminescent luciferase expression using IVIS. (B) Organs were isolated and bacterial 
expression of luciferase was determined in spleen (Spl), liver (Liv) and lung (Lu) 5min., 30min., 
and 60min. after CASP procedure.  
 
As expected bacteria disseminated in the organism very fast. Five minutes after the CASP 
procedure bacteria were detected in the peritoneum, 30 minutes after surgical treatment 
bacteria were found in the liver. 60 minutes after CASP, E.coli lux reached lung and 
spleen. Mice were septic after 150 minutes as bacteria could be found in all organs (Figure 
4.1 A and B). 
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Next we investigated the immune status of mice surviving CASP sepsis. Therefore, mice 
that had survived CASP were immunized intravenously (i.v.) 24 hours after surgery with 
5x109 virus particles recombinant adenovirus expressing ovalbumin (AdOVA). Following 
infection the OVA-derived MHC class I peptide SIINFEKL (S8L) is presented on H-2k
b
 
and peptide-specific CD8
+ 
T cells are activated and subsequently undergo expansion and 
differentiate into cytotoxic T lymphocytes (CTL). Five days post infection OVA-specific 
cytotoxicity was analyzed in spleens of mice using an in vivo cytotoxicity assay. Untreated 
mice generated a strong CTL response upon AdOVA infection whereas mice that under-
went CASP almost completely lack an effective CTL response (Figure 4.2 A). To investi-
gate whether CASP procedure itself or the translocating bacteria contribute to the suppres-
sion of CTL responses we injected either fecal suspension or E.coli intraperitoneally (i.p.). 
Mice treated with feces or E.coli i.p. showed a strong reduction of cytotoxic T cell activity 
after adenoviral challenge (Figure 4.2). Furthermore i.v. application of E.coli revealed that 
systemic distribution of bacteria lead to suppression of antigen-specific CTL responses 
(Figure 4.2). 
 
Figure 4.2   Mice surviving CASP lacked antigen-specific CTL responses against a subsequent 
AdOVA infection 
C57BL/6 wild type mice were infected 24 hours after (A) CASP procedure or (B) after having re-
ceived fecal suspension intraperitoneally (i.p.), 1x10
7
 E.coli i.p. or 1x10
6
 E.coli intravenously (i.v.) 
with 5x10
9
 virus particles AdOVA. OVA-specific CTL responses were determined in spleens five 
days post AdOVA infection. Representative data of two independent experiments are shown with 
(A) n=5 mice per group and (B) n=3 mice per group.  
 
4.1.2 Bacterial translocation after sham treatment 
To exclude that the surgical procedure itself affects the induction of CTL responses we 
performed sham operations. Mice having undergone non-invasive sham operation (OP) 
were examined for bacterial translocation using a classical microbiological technique.      
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24 hours after mock treatment organs were isolated and homogenates of the organs were 
prepared. Cell suspensions were plated on McConkey agar and after overnight incubation 
colony forming units (CFU) were determined. Surprisingly even sham operation led to 
translocation from the gut to distant organs. We detected vast amounts of gram negative 
bacteria in liver, lung and, minor amounts in mesenteric lymph nodes. The spleen was af-
fected in only few animals and the bacterial burden of those was low. Living bacteria were 
absent in blood (Figure 4.3). However bacterial load was very different between mice.   
 
 
Figure 4.3   Bacterial loads of organs 3h after sham treatment 
Blood and cell suspensions of lung, liver, spleen, and mesenteric lymph nodes (mLN) of sham 
treated C57BL/6 wild type mice were plated on MacConkey Agar. After 24 hours incubation at 
37°C colony forming units (CFU) of gram negative bacteria were determined and calculated per 
gram tissue. Data presented as mean +/- SEM with n=5 mice per group. Representative data from 
one out of three independent experiments are depicted. (n.d.=not detectable). 
 
To determine if mice, which had undergone sham treatment, were able to mount antigen-
specific CTL responses, we intravenously infected mice with 5x10
9
 virus particles     
AdOVA. Five days after immunization OVA-specific CTL responses were quantified in 
spleens by using an in vivo cytotoxicity assay.  
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Figure 4.4   Sham treated mice induced strong CTL responses upon infection with AdOVA 
C57BL/6 wild type mice were infected 24 hours after sham treatment with AdOVA and OVA-
specific CTL responses were determined in spleens five days post AdOVA infection. Data are pre-
sented as mean +/- SEM with n=3 mice per group. Representative data out of two independent 
experiments are depicted.  
 
Interestingly, we observed a different distribution of bacteria in animals having undergone 
CASP compared to sham treated mice. In the CASP model bacteria spread very fast result-
ing in a systemic distribution, while in sham treated mice bacteria where mainly found in 
the liver. Interestingly, in contrast to the CASP model, in which CTL responses were im-
paired, sham treatment and bacterial translocation did not impair the induction of cytotoxic 
T cell responses. (Figure 4.4)  
4.2 E.coli-mediated immune suppression is time and dose dependent 
The observed suppression of adaptive immunity by bacteria was surprising as TLR ligands 
are known to be immunostimulatory and generally result in the activation of immunity 
(Akira et al., 2006). Therefore, we asked whether adaptive immune suppression was a gen-
eral effect mediated by circulating bacteria and whether it was time and dose dependent. 
To this end mice were injected i.v. with 1x10
7
 E.coli seven days (d-7), five days (d-5) or 
one day (d-1) prior to infection with adenovirus expressing luciferase, ovalbumin, and GFP 
(AdLOG). Five days after immunization with adenovirus antigen-specific cytotoxic T cell 
responses were assayed in spleens. OVA-specific CTL responses were significantly im-
paired if E.coli was administered five days prior to AdLOG infection, whereas CTL res-
ponses were completely abolished if E.coli was given one day before adenoviral challenge. 
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Administration seven days prior to adenovirus infection had only a minor influence on the 
generation of CTL responses (Figure 4.5 A). Thus, suppression of CTL responses by sys-
temic E.coli depended on the time point of E.coli injection.  
To monitor a possible impact of different bacterial doses on the induction of CTL res-
ponses we injected three different doses of E.coli (1x10
5
, 5x10
4
 and 1x10
4
) intravenously 
into mice one day prior to AdLOG infection. A clear dose dependency of E.coli-mediated 
CTL suppression was recognized. 1x10
5
 bacteria almost completely inhibited the genera-
tion of CTL responses and CTL activities were still remarkably reduced if 5x10
4
 E.coli 
were injected. Even 1x10
4
 bacteria significantly impaired the induction of OVA-specific 
cytotoxicity (Figure 4.5 B). 
  
Figure 4.5   E.coli mediated suppression was time and dose dependent 
(A) Wild type mice were left untreated or infected intravenously with 1x10
7
 E.coli on day 7, 5 or 1 
before infection with AdLOG. (B) Wild type mice were infected with 1x10
5
, 5x10
4
 or 1x10
4
 E.coli 
one day prior infection with AdLOG. Five days after adenoviral infection OVA-specific CTL res-
ponses were determined. Representative data are shown as mean +/- SEM out of three individual 
experiments with n=3 mice per group. (ns=not significant) 
 
So far, we demonstrated that systemic antigen-specific CTL responses against adenovirus 
were inhibited if mice had previously been infected with E.coli. Based on these findings 
that systemic E.coli led to the suppression of subsequent CTL responses, we wondered 
whether the lack of cytotoxic activity was due to tolerization (Steinman et al., 2003) or 
rather due to an absent generation of antigen-specific effector CD8 T cells.  Moreover, we 
investigated how a subsequent injection of E.coli influenced the generation of CTL res-
ponses against an already established adenovirus infection. To address these questions 
mice received an intravenous injection of E.coli either one day before or one day after ade-
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novirus infection. CTL responses were analyzed in spleens five days post adenoviral chal-
lenge. The generation of endogenous OVA-specific CD8 T cells was assessed by flow cy-
tometric analysis of S8L/H-2Kb specific pentamers.  
 
 
Figure 4.6   E.coli suppressed or stimulated CTL responses depending on the time point of 
adenoviral infection  
C57BL/6 wild type mice were infected with 5x10
5
 E.coli either one day prior or one day after ade-
noviral infection. (A) CTL responses were determined in spleens five days after viral infection and 
are depicted as mean +/- SEM with n=3 mice per group. (B) The percentage of endogenous OVA-
specific CD8 T cells was assayed by S8L/H-2Kb pentamer staining of splenocytes and subsequent 
flow cytometric analysis. Dot plots are shown for one representative mouse out of three mice. Rep-
resentative data of at least two independent experiments are shown. 
 
Compared to mice infected with AdLOG only, administration of E.coli one day before 
adenoviral infection resulted in suppression of OVA-specific cytotoxic activities, whereas 
CTL responses were significantly enhanced in mice that had been infected one day after 
adenovirus injection (Figure 4.6 A). In line with these results, the generation of endogen-
ous OVA-specific CD8 T cells was remarkably impaired as the percentage of OVA-
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specific CD8 positive T cells was clearly reduced if E.coli was given prior to adenovirus 
infection. The percentage of OVA-specific CD8 T cells was increased if E.coli was given 
one day after adenoviral infection (Figure 4.6 B). Taken together, we conclude that a sys-
temic administration of E.coli prior to adenoviral infection causes suppression of adaptive 
immunity, whereas the generation of antigen-specific CD8 T cells responses is augmented 
if E.coli was given after an adenovirus infection.  
4.3 E.coli-mediated suppression of CTL responses is not restricted to 
adenovirus infection 
Based on our findings that E.coli suppressed the CTL response against a subsequent ade-
noviral infection, we wondered if this phenomenon was restricted to adenoviral vectors. 
We examined if CTL responses were impaired against distinct pathogens as well by a pre-
vious injection of E.coli. Wild type mice were infected i.v. either with 1x10
3
 CFU OVA-
expressing Listeria monocytogenes (LmOVA), 1x10
5
 PFU Herpes simplex virus type I 
(HSV-1) or 1x10
5
 PFU Influenza A PR8/H1N1 virus.  
 
 
Figure 4.7   E.coli mediated suppression of CTL responses against various pathogens 
C57BL/6 wild type mice were infected with 5x10
3
 CFU LmOVA (A), 1x10
5
 PFU Influenza 
APR/8/H1N1 (B) or 1x10
4
 PFU HSV-1 one day after intravenous injection of 5x10
5
 E.coli. Anti-
gen-specific CTL responses were determined in spleens five days after infection. Results are pre-
sented as mean +/- SEM and representative data of two independent experiments are shown.  
 
Indicated groups received an i.v. injection of 5x10
5
 E.coli one day prior to infection. We 
detected strong antigen-specific CTL responses against LmOVA, HSV-1 or Influenza vi-
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rus, which were significantly suppressed in mice previously infected with E.coli (Figure 
4.7). Thus suppression of antigen-specific CTL responses by bacteremia is not restricted to 
adenoviral infection. 
4.4 Different distribution of E.coli after CASP and sham treatment is 
due to the retention of gut-derived bacteria in the liver  
Although bacterial translocation from the gastrointestinal tract is a well described pheno-
menon, the route of translocating bacteria is still unknown (Berg, 1985, 1990, 1992, 1995; 
Deitch and Berg, 1987a; Deitch et al., 1990a). With respect to the anatomy of the gut two 
distinct routes appear possible: first, translocation via the mesenteric lymph nodes or 
second, dissemination via the gut draining blood vessels. Although the bacterial load of the 
mesenteric lymph nodes was high we could detect tenfold more bacteria in the liver (Fig-
ure 4.3). Therefore we hypothesized that translocation mainly occurred via the blood route. 
Based on these results, we asked if the liver was able to retain bacteria, which had translo-
cated from the intestinal tract and thus prevented systemic distribution of gut-derived bac-
teria. 
4.4.1 The liver retains bacteria after intraportal injection 
As mentioned before, sham treatment led to very variable extents of bacterial translocation 
in mice. To ensure standardized experimental conditions, which allowed studying the ef-
fect of bacterial translocation into the liver we directly injected a defined number of E.coli 
into the portal vein. We then compared bacterial load after i.v. injection with intraportal 
(i.po.) administration.  
While systemic application of E.coli via the tail vein led to comparable amounts of bacteria 
in liver, spleen and blood, injection of E.coli into the portal vein resulted in a higher bac-
terial load in the liver and reduced bacterial loads in spleen, lung and blood (Figure 4.8 A). 
Thus, it could be speculated that the liver has the capability to retain bacteria translocated 
from the gut, thereby preventing a systemic and thus splenic distribution of bacteria.  
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Figure 4.8   Different distribution of E.coli after intravenous or intraportal injection. 
(A) C57BL/6 wild type mice were injected with 5x10
6
 E.coli either i.v. or i.po.. 18h after infection, 
CFU were assayed in liver, lung, spleen and blood. Representative data are shown from two inde-
pendent experiments with n=4 mice per group. (B) 1x10
4
, 1x10
5
 or 1x10
6
 CFU of E.coli were in-
jected either i.v. or into the portal vein (i.po.) of C57BL/6 wild type mice one day prior to infection 
with AdOVA. OVA-specific cytotoxicity was determined on day five after adenoviral challenge in 
spleens. Data presented as +/- SEM of two independent experiments with n=3 mice. (ns=not signif-
icant) 
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We have recently shown that the spleen is essential for the induction of adenovirus-specific 
CTL responses (Backer et al., 2010). Furthermore suppression of CTL responses correlates 
with the amount of bacteria reaching the spleen (Figure 4.5 B). Thus, in order to analyze a 
dose dependency of the CTL suppression, we injected E.coli in different concentrations 
either i.v. or i.po.. Indeed, intravenous injection caused suppression in a dose dependent 
manner, whereas mice that had received an i.po. injection of E.coli generated significantly 
higher CTL responses than intravenously treated mice (Figure 4.8 B). We therefore con-
clude that the liver could retain bacteria entering via the portal vein, thus preventing a sys-
temic distribution and subsequent immunosuppression.    
4.4.2 E.coli is efficiently taken up by liver resident macrophages and bacterial 
clearance is associated with TNF secretion and signaling.   
To investigate if the accumulation of E.coli in the liver was either a passive effect or an 
active retention including the uptake of bacteria we made use of a specific fluorescent dye. 
The pHrodo™ dye is a specific sensor for endocytosis, which is non fluorescent at neutral 
pH and fluoresces  in acidic environments, for example in endophagosomes. Here we in-
jected pHrodo™ E.coli Bioparticles into the portal vein of mice and the liver was removed 
one hour after injection. A flowcytometric analysis of liver cells was performed. As shown 
in Figure 4.9, pHrodo™ E.coli Bioparticles were taken up within the liver. To discriminate 
which cell type takes up the pHrodo™ E.coli Bioparticles we performed flowcytometric 
analysis of liver cells and splenocytes. As we were interested in resident cells and their 
ability to phagocytose bacteria, we eliminated blood born phagocytic cells, such as neutro-
phile granulocytes, by perfusion of the liver and spleen with PBS. We observed that pre-
dominantly hepatic CD11b positive cells had phagocytosed the particles whereas CD11c 
positive cells had taken up the particles to a lesser extent (Figure 4.9).  
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Figure 4.9   CD11b positive cells phagocytosed E.coli particles predominantly in liver and 
spleen. 
C57BL/6 wild type mice were injected i.po. with 200µl of pHrodo™ E.coli Bioparticles. One hour 
after injection mice were sacrificed and perfused with collagenase solution. Liver and spleen cells 
were purified, stained for CD11b or CD11c and analyzed for particle uptake by flow cytometric 
analysis. Representative histograms of one mouse out of four are shown. 
 
As Kupffer cells constitute 80-90% of tissue macrophages present in the body, they display 
the most prominent resident macrophage population, which is well known to potently clear 
opsonized pathogens from the circulation (Bilzer et al., 2006; Fox et al., 1987). Therefore, 
we investigated the role of Kupffer cells in bacterial clearance. To analyze whether these 
liver resident macrophages contributed to bacterial clearance we injected E.coli i.po. into 
wild type mice or into mice that had been depleted from macrophages with clodronate li-
posomes. Bacterial clearance was determined 3 or 18 hours after injection of bacteria. In 
wild type mice bacteria were cleared to 90% in all organs after 18 hours upon injection 
(Figure 4.10). However, depletion of macrophages resulted in an increase in bacterial load 
in all organs (liver, spleen, and lung). Particularly bacterial load in the liver of clodronate 
liposomes treated mice was 1000 fold higher after 18h than in untreated mice (Figure 4.10) 
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Figure 4.10    Bacterial clearance after i.po. injection of E.coli depended on macrophages 
Mice were infected with 1x10
6
 E.coli intraportally alone (filled squares) or received 200µl clodro-
nate liposomes (Clolip) i.v. 24h prior to E.coli infection (open squares). Bacterial load was deter-
mined after 3 or 18 hours. After blood samples were taken, mice were perfused with PBS and lung, 
spleen, and liver were removed. Organ suspensions were prepared and plated on McConkey agar. 
24 hours later colony forming units were counted on plates. Representative data of three indepen-
dent experiments are shown with n=3 mice per group. (n.d.=not detectable)  
 
The most potent inflammatory mediator secreted by Kupffer cells upon stimulation with 
LPS and other bacterial structures is the tumor necrosis factor (TNF) (Hoedemakers et al., 
1995). Therefore we investigated the role of TNF in bacterial clearance. Wild type and 
TNF receptor I and II deficient mice (TNFRI/II) or mice treated with Infliximab, an anti-
TNF antibody, were infected i.p. with E.coli and bacterial burden was calculated as CFU in 
different organs 18h post infection. Blockade of secreted TNF or inhibition of TNF signal-
ing via TNF receptors resulted in an increase of bacterial burden mainly in lung and liver 
compared to wild type mice (Figure 4.11).  
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Figure 4.11    Blocking of secreted TNF or TNF signaling resulted in an increase in bacterial   
burden especially in liver and lung  
Wild type mice, mice deficient in TNFR I and II (TNFR 
-/-
) or mice treated with 100µg anti-TNF 
antibody (aTNF AB) (Infliximab) were infected with 1x10
6
 E.coli i.po. Bacterial load was deter-
mined 18h after infection. After blood samples had been taken mice were perfused with PBS and 
lung, spleen, and liver were homogenized. Suspended organs were plated on McConkey Agar. 
Colony forming units were counted on plates after 24h of incubation. Representative data of two 
independent experiments are shown with n=3 mice per group. (n.d.=not detectable) 
 
 
In summary, we conclude from our data that macrophages and most likely Kupffer cells 
play a crucial role in the retention and clearance of gut-derived bacteria. Furthermore, se-
cretion of TNF and signaling via the TNF receptor are critically involved in this process.  
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4.5 The spleen is essential for induction of effective CTL response to 
adenovirus 
4.5.1 Suppression of CTL responses against a systemic adenovirus infection is 
mediated by systemically circulating E.coli 
Based on our findings that bacteremia had caused suppression of the antigen-specific CTL 
responses we wondered whether suppression was restricted to systemic adenoviral infec-
tions or whether also local adenoviral infections were suppressed by E.coli. Therefore, we 
infected mice i.v. with 5x10
5
 E.coli. Then, one group of mice received a systemic injection 
of adenovirus (i.v.), while the second group was infected intranasally. To ensure that intra-
nasal administration of AdLOG exclusively resulted in a local infection of the lung those 
animals were analyzed for expression of luciferase in the IVIS system. Intranasal applica-
tion of AdLOG exclusively resulted in a tracheobronchial infection, whereas AdLOG giv-
en i.v. infected the liver and spleen (Figure 4.12 C). Therefore, a clear distinction between 
the locus of CTL induction could be made. Five days after immunization, CTL responses 
of i.v. and of intranasally infected mice were determined in the spleen and lung draining 
lymph nodes, respectively. Cytotoxic activities were significantly reduced in mice that had 
been infected systemically with AdLOG but not in mice infected intranasally (4.12 A, B). 
Thus we concluded that suppression of CTL responses exclusively occurs if both E.coli 
and adenovirus are systemically circulating and induction of local immunity is not im-
paired by bacteremia.   
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Figure 4.12   Induction of local immunity was not affected by bacteremia 
C57BL/6 wild type mice were infected with 1x10
6
 E.coli i.v. or left untreated. 24 hours later mice 
were infected either (A) intravenously or (B)  intranasally with AdLOG. OVA-specific CTL res-
ponses were assessed five days after adenoviral infection in (A) spleens or (B) in the tracheobron-
chial lymph node. (C) Adenoviral burden was analyzed two days after infection with AdLOG by in 
vivo imaging. Representative data are shown as mean +/- SEM (n=4 mice per group) of two inde-
pendent experiments. (ns=not significant) 
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4.5.2 Splenic DCs and macrophages contribute to the generation of antigen-specific 
cytotoxic T cells upon adenoviral infection.  
Since the spleen is a secondary lymphoid organ, which is known to be involved in the in-
duction of CTL responses we wanted to elucidate the importance of the spleen in our expe-
rimental setup. We analyzed splenectomized mice for their ability to induce CTL responses 
upon systemic adenovirus infection. Splenectomized and sham treated mice were infected 
three days after surgery with AdOVA. Five days after infection antigen-specific CTL res-
ponses were quantified in blood. As shown in Figure 4.13, splenectomized mice were not 
capable to induce a CTL response upon systemic infection with adenovirus. Although ade-
novirus mainly infected the liver upon a systemic injection (Figure 4.12), importantly the 
generation of CTL responses strictly relied on the spleen. 
 
Figure 4.13   The spleen and an intact splenic structure were essential for the generation of 
efficient CTL responses after systemic adenoviral infection 
C57/BL6 wild type or splenectomized (SplX) mice were infected three days after surgery by an 
intravenous injection of AdOVA. One group of splenectomized mice was reconstituted with single-
cell suspensions of splenocytes (SplX+cells) one day prior to adenoviral infection. Another group 
received splenic autotransplants, which were placed into the renal capsule seven days before ade-
noviral challenge (SplX AT). OVA-specific cytotoxicity was determined five days after infection 
in blood.  Data are presented as mean +\- SEM. Data from two independent experiments are shown. 
  
In the following experiments we asked the question whether it was possible to rescue the 
CTL response by reconstituting splenectomized mice with single-cell splenocyte suspen-
sions, given i.v. one day prior to infection with AdOVA. However, regardless of whether 
splenectomized mice were reconstituted with splenocytes or left untreated these animals 
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failed to induce adenovirus-specific CTL responses (Figure 4.13). These results indicate 
that an intact splenic architecture is essential for the induction of adenoviral CTL res-
ponses. To confirm this hypothesis splenectomized mice received autologous splenic auto-
transplants, which were placed into the renal capsule seven days prior to AdOVA infec-
tion. The induction of OVA-specific CTL responses was measured in these mice by per-
forming an in vivo cytotoxicity assay five days post AdOVA infection. CTL responses 
were inhibited in splenectomized mice, whereas the re-transplantation of small pieces of 
the spleen partially restored the capability to generate a CTL response (Figure 4.13). Taken 
together, these results imply that efficient antigen-specific CTL responses upon systemic 
adenoviral infections were exclusively generated in the spleen and that an intact splenic 
structure is a prerequisite for efficient CTL induction. 
Based on our data that the spleen and its unique architecture were essential for the initia-
tion of a strong CTL response, we wondered which splenic cell types were mainly in-
volved in the induction of these CTL responses. It is known that macrophages in the mar-
ginal zone efficiently take up blood born antigens and they are considered to be involved in 
the induction of CTL responses (Backer et al., 2010). In addition, immature, 
CD8+DEC205+ dendritic cells (DCs) present in the marginal zone are professional anti-
gen-presenting cells, which exhibit a crucial role in initiating primary T cell responses 
(Belz et al., 2005; de Haan et al., 2000). To study a possible role of these two cell subsets 
for the induction of CTL responses in response to adenoviral infection we depleted either 
macrophages or DCs. Macrophages were depleted by an i.v. injection of clodronate lipo-
somes one week before AdLOG infection. To deplete splenic DCs we made use of a trans-
genic mouse expressing the diphtheria toxin receptor under the CD11c promoter 
(CD11cDTR). CD11c positive cells were depleted by injection of diphtheria toxin (DTX) 
one day prior to adenoviral infection. Mice depleted of macrophages (Figure 4.14 A) or 
dendritic cells (Figure 4.14 B) were not capable to induce CTL responses upon adenoviral 
infection, whereas control mice treated with PBS-formulated clodronate liposomes or wild 
type mice injected with DTX generated a strong OVA-specific CTL response. From these 
results we concluded that both macrophages and dendritic cells are essential for the stimu-
lation of a potent antigen-specific CTL response. 
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Figure 4.14   Mice depleted of either macrophages or dendritic cells failed to induce adenovi-
rus-specific CTL responses 
(A) C57BL/6 wild type mice were depleted from macrophages with clodronate liposomes (Clolip) 
or left untreated. One day after depletion mice were infected with AdLOG and CTL activity was 
determined five days after adenoviral infection. (B) C57BL/6 wild type mice and CD11cDTR 
mice, were infected with AdLOG alone or received an intraperitoneal injection of 800ng diphtheria 
toxin (DTX) one day prior to challenge with AdLOG. OVA-specific cytotoxicity was determined 
in spleens five days post adenovirus challenge. Data are presented as mean +/- SEM with n=3 mice 
per group from two independent experiments.(ns=not significant) 
 
To further investigate which cell type might be influenced in its capability to respond ade-
quately to adenoviral infection in the presence of E.coli, we analyzed the distribution of 
E.coli as well as the cellular infection pattern in spleens of adenovirus with and without 
E.coli pretreatment. To determine the influence of E.coli on adenovirus infection, mice 
were infected with GFP-expressing adenovirus alone or were pretreated with E.coli one 
day prior to adenoviral infection (Figure 4.15 A). Moreover, in order to evaluate the locali-
zation of E.coli in the spleen by histology, an additional group of mice received an i.v. in-
jection of pHrodo™ E.coli Bioparticles. From all groups of mice, spleens were isolated for 
histological analysis one hour post injection. PHrodo™ E.coli Bioparticles were predomi-
nantly found in the marginal zone of the spleen, where they co-localized with metallophil-
lic marginal zone macrophages (MMMs) (Figure 4.15 B)  
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Figure 4.15   Systemic E.coli were taken up in the marginal zone of the spleen and diminished 
adenoviral burden. 
(A) C57BL/6 wild type mice were infected with 5x10
7
 E.coli or left untreated. On the following 
day mice received 1x10
11
 VP AdLOG intravenously and spleens were removed for histological 
analysis. Cryo sections were prepared and stainings for CD11c to identify DCs (blue) and for Ser-4 
to identify metallophilic marginal zone macrophages (red) were performed. Expression of GFP by 
AdLOG infected cells is displayed in green. (B) 200µl of pHrodo™ E.coli Bioparticles were admi-
nistered intravenously and cryo sections were prepared one hour after infection. DCs were stained 
with CD11c (blue) and metallophilic marginal zone macrophages with Ser-4 (green). PHrodo™ 
E.coli Bioparticles showed red fluorescence upon uptake.  
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As seen in figure 4.15 A adenovirus mainly infected cells in the marginal zone. A strong 
reduction in adenoviral burden was noticed in mice pretreated with E.coli one day before 
AdLOG infection (Figure 4.15 A).  
To exclude that E.coli had simply impaired the ability of MMM to be infected with adeno-
virus and to ensure that cells of the marginal zone gained equal amounts of antigen, wild 
type and septic mice were injected i.v. with soluble OVA together with a stimulatory anti-
CD40 antibody to ensure activation of DCs. As mice showed impeded CTL responses 
upon immunization after E.coli treatment we concluded that bacteria-mediated suppression 
was not only to the result of a reduced viral antigen load but rather depended on additional 
mechanisms (Figure 4.16 A).  
MMMs are essential for cross-presentation of blood-borne antigens by splenic dendritic 
cells (Backer et al., 2010). To investigate whether macrophages or dendritic cells were 
compromised in their function in response to a previous injection of E.coli we made use of 
OVA-coupled antibodies which directly target the antigen to these specific cell types 
(Backer et al., 2010). Using this approach OVA is targeted either to MMMs by coupling to 
a Siglec-1 antibody (SIGLEC-1-OVA) or to CD8+DEC205+ DCs by coupling to an anti-
body directed against DEC205 (DEC205-OVA).  
 
Figure 4.16   Suppression was not due to reduced adenoviral burden and affects both macro-
phages and dendritic cells 
C57BL/6 mice were injected intravenously with 25µg activating aCD40 mAb (1C10) and (A) 
100µg Ovalbumin (OVA slb), (B) 5µg DEC205-OVA or Siglec-1-OVA alone or received 1x10
5
 
E.coli one day prior to immunization. CTL responses were determined in spleens on day five after 
immunization. Each bar presents the mean +/- SEM with n=3 mice per group. Representative data 
of two independent experiments are shown. (n.d.=not detectable)  
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If administered to wild type mice OVA coupled to DEC205 and Siglec-1 induced a CTL 
response. In contrast, CTL responses were significantly reduced or even absent in mice 
treated with E.coli one day prior to immunization with OVA-coupled DEC205 or Siglec-1 
(Figure 4.16 B). From these results we concluded that DCs as well as MMM were affected 
by bacteremia as they were not able to induce CTL responses after exposure to E.coli.    
 
4.6 IL-10 is not associated with E.coli-mediated suppression of CTL 
responses  
IL-10 is known to be a very potent anti-inflammatory cytokine. IL-10 is expressed by 
many cells of the adaptive immune system such as a broad variety of T cells and B cells as 
well by cells of the innate immune system, for instance DCs, macrophages, mast cells, NK 
cells, eosinophiles and neutrophils upon stimulation with PAMPs (Siewe et al., 2006; 
Zhang et al., 2009). As we observed suppression of CTL responses by E.coli, we specu-
lated whether IL-10 production might be stimulated upon E.coli administration and wheth-
er it might play a role in immune suppression. Moreover, we intended to identify which 
cell types produced IL-10 in the spleen upon systemic exposure to E.coli.  
 
 
Figure 4.17   Splenic Macrophages produced IL-10 upon E.coli stimulus  
IL-10 GFP-reporter mice left untreated (tinted histograms) or received 5x10
5
 E.coli intravenously 
(open histograms). One day post infection IL-10-GFP expression was examined by flowcytometric 
analysis of splenocytes. Granulocytes were identified by GR-1
pos
, Macrophages by CD11b
pos
 and 
F4/80
pos
, and dendritic cells by CD11c
pos
. Representative histograms of one mouse out of three 
mice are shown. 
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To this end, we made use of IL-10 knockin reporter mice, which express GFP under the 
IL-10 promoter (Bouabe et al., 2008).  
We assayed GFP expression in splenoctyes by flowcytometric analysis 24h after systemic 
exposure to E.coli. Macrophages (CD11b
pos
) were identified as the main producers of IL-
10 after exposure to E.coli while DCs (CD11c
pos
) and Granulocytes (GR-1
pos
) did not pro-
duce IL-10 (Figure 4.17). As we know that macrophages were essential in induction of 
potent CTL responses (Figure 4.14 B) and IL-10 was secreted by macrophages we specu-
lated whether IL-10 was involved in the suppression of CTL responses. 
To this end, we infected C57BL/6 wild type mice or IL-10 ko mice either with AdLOG 
alone or injected them with 5x10
5
 E.coli i.v. one day before adenoviral infection. OVA-
specific cytotoxicity was measured in spleens five days after infection. E.coli-mediated 
suppression of OVA-specific CTL response was still observed in IL-10 deficient mice in-
dicating that IL-10 was not involved in the suppression of CTL responses by E.coli (Figure 
4.18). 
 
 
 
Figure 4.18   IL-10 was not involved in E.coli-mediated CTL suppression  
C57BL/6 wild type mice or mice deficient in IL-10 were infected with AdLOG alone or received 
5x10
5
 E.coli one day prior to adenoviral infection. OVA-specific CTL responses were determined 
five days post AdLOG infection in the spleen. Data are presented as mean +/- SEM (n=3) 
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4.7 E.coli suppresses antigen-specific CTL responses in a TLR 4 and 
TRIF dependent manner 
4.7.1 TLR4 signaling promotes suppression of CTL responses upon bacteremia 
E.coli contains a broad variety of TLR ligands, such as CpG recognized by TLR9, pepti-
doglycan sensed by TLR2 and LPS, which is recognized by TLR4 (Medzhitov et al., 
1997). It has been recently shown that TLR4 and its downstream signaling play a crucial 
role in the immunophathology of sepsis (Beutler and Rietschel, 2003). Blockade of TLR4 
by antibodies renders mice resistant towards septic shock (Roger et al., 2009). Therefore, 
we asked if TLR signaling was involved in the suppression of CTL responses as well. To 
study the contribution of TLR ligands to sepsis-mediated immunosuppression we used 
mice deficient in TLR2, TLR9 or TLR4 and analyzed their capability to generate effective 
CTL responses upon adenoviral infection and a previous systemic exposure to E.coli. Wild 
type and TLR-deficient mice were infected intravenously with 5x10
5
 E.coli one day prior 
to adenoviral infection. Antigen-specific T cell responses were determined in spleens five 
days after AdLOG challenge. CTL suppression was still obtained in TLR2- and TLR9-
deficient mice, indicating that E.coli-mediated CTL suppression was independent of TLR2 
and TLR9 signaling (Figure 4.19 A and B). However, no inhibition of antigen-specific 
CTL responses by E.coli was observed in TLR4-deficient mice. These results clearly dem-
onstrated that E.coli-mediated CTL suppression was exclusively dependent on TLR4 (Fig-
ure 4.19 C). 
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Figure 4.19   E.coli-mediated suppression exclusively depended on TLR4 signaling 
C57BL/6 wild type mice or mice deficient in TLR2 (A), TLR9 (B) or TLR4 (C) were injected with 
5x10
5
 E.coli intravenously one day before infection with AdLOG. OVA-specific cytotoxic T cell 
activities were quantified in spleens on day 5 after adenoviral infection. Data are shown as mean 
+/- SEM with n=3 mice per group. Representative data of at least two independent experiments are 
presented. 
 
4.7.2 CD14 is not involved in E.coli mediated CTL suppression 
Since TLR4 exclusively mediated the suppression of antigen-specific CTL responses after 
infection with E.coli, we speculated that LPS was the main suppressive constituent of 
E.coli. LPS can be transferred to TLR4 by the LPS binding protein (LBP) and CD14 which 
therefore play important roles in promoting innate immunity to gram negative bacteria 
(Kitchens and Thompson, 2005). Moreover, it is known that CD14 can promote or atte-
nuate cell responses towards LPS (Kitchens et al., 2001) and is consequently an attractive 
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clinical target to prevent septic shock caused by endotoxin. As monoclonal antibodies di-
rected at CD14 have been tested in phase I clinical trials (Reinhart et al., 2004) we asked 
for the relevance in our model of sepsis-induced immunosuppression. Thus, we infected 
mice deficient in CD14 with 5x10
5
 E.coli i.v. one day prior to adenoviral infection. On day 
five after AdLOG infection antigen-specific CTL responses were measured in spleens. 
Astonishingly, although CD14 seems to be a potent regulator of endotoxin shock it was 
clearly not involved in E.coli-mediated CTL (Figure 4.20). 
 
 
Figure 4.20   CD14 was not involved in E.coli-mediated CTL suppression 
C57BL/6 wild type mice and mice deficient in CD14 were left untreated or given 5x10
5
 E.coli 
intravenously one day before infection with AdLOG. Five days after adenoviral infection OVA-
specific cytotoxic CTL responses were assessed in spleens. Data are presented as mean +/- SEM 
with n=3 wild type mice per group and n=5 CD14 deficient mice per group. 
 
 
4.7.3 TRIF exclusively contributes to suppression of CTL responses  
Based on our finding that TRL4 is the main receptor involved in CTL suppression by 
E.coli we wondered which adaptor molecule downstream of TLR4 was responsible for the 
suppression. In most TLRs except TLR3 downstream signaling is mediated by the TIR 
domain containing adaptor molecule MyD88 (Akira et al., 2006). The second TLR adaptor 
molecule is the TIR-domain-containing adapter-inducing interferon-β (TRIF) which in-
itiates downstream signaling of TLR3 and TLR4. In contrast to MyD88, TRIF can activate 
NF-κB and additionally interferon regulatory factor 3 (IRF3) which activates the interfe-
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ron-β transcription. TLR4 is kind of special among the TLRs because it is the only TLR 
that is able to recruit both adaptor molecules, MyD88 and TRIF. Therefore we investigated 
if MyD88 and TRIF promoted the suppression of CTL responses upon TLR4 stimulation.  
 
 
   
Figure 4.21   E.coli suppressed adeno-specific CTL responses in a TRIF dependent manner 
C57BL/6 wild type mice or mice deficient either in (A) MyD88xTRIF (B) MyD88 or (C) TRIF 
were infected intravenously with 5x10
5
 E.coli or left untreated. One day after induction of bactere-
mia mice were infected with 5x10
9
 virus particles AdLOG. OVA-specific cytotoxicities were quan-
tified in spleens five days post infection. Data are displayed as mean +/- SEM with n=3 mice per 
group. Representative data of at least two independent experiments are depicted. 
 
Inhibition of TLR4 downstream signaling clearly contributed to E.coli mediated suppres-
sion of adenovirus-associated CTL responses as mice deficient in both MyD88 and TRIF 
showed no suppression (Figure 4.21 A). Surprisingly, MyD88 did not contribute to E.coli-
mediated suppression of adenovirus-specific CTL responses. Instead CTL suppression was 
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exclusively induced by TRIF signaling, as only mice lacking TRIF were able to induce 
strong CTL responses after systemic pretreatment with E.coli (Figure 4.21 B and C). 
 
4.7.4 Type I interferons are induced after bacteremia and contribute to suppression 
of CTL responses 
 Since the observed inhibition of CTL responses by E.coli was completely dependent on 
TRIF signaling, we further studied the role of TRIF regulated genes and its downstream 
products. It is well known that LPS-stimulated interferon-β (IFN-β) induction via TLR4 is 
entirely TRIF dependent (Yamamoto et al., 2003b) and TRIF is identified as a regulator of 
interferon (IFN) transcription via IRF3 and IRF7 (Fitzgerald et al., 2003b). For that reason 
we examined if TRIF signaling via IRF3 and IRF7 and consequently type I IFNs were in-
volved in the observed absence of CTL responses upon systemic E.coli exposure. To first 
address the question whether type I IFNs were induced upon infection with E.coli, we 
made use of mice expressing a functional human myxovirus resistance protein (MxA), a 
protein, which is normally lacking in most inbred mouse strains (Shuai, 1994). MxA is a 
GTPase that accumulates to high levels in the cytoplasm of
 
interferon-treated cells and can 
be stained in histology by a specific antibody (Pavlovic et al., 1995; Wenzel et al., 2005b). 
Thus, detection of MxA correlates with type I IFN production.  
 
 
 
Figure 4.22   MxA protein was expressed in the spleen after infection with E.coli 
C57BL/6 wild type mice or mice expressing the MxA protein were infected with 5x10
5
 E.coli i.v.. 
One day after bacterial infection histological sections were performed from formalin-fixed, paraf-
fin-embedded spleens. Standard haematoxylin and eosin staining followed by immunohistochemi-
stry for MxA protein was done. Shown is one mouse out of three for each group respectively. Orig-
inal magnification x200 and x400 small panel.  
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MxA expressing mice were infected with 5x10
5
 E.coli and histology of the spleens was 
performed one day after infection. Systemic administration of E.coli led to robust expres-
sion of MxA protein in the marginal zone as well as in the white pulp of the spleen (Figure 
4.22) suggesting that type I IFNs were indeed induced upon systemic E.coli in the spleen.  
 
As we could show that type I IFNs were induced after challenge with E.coli we wondered 
whether mice that lack the IFN-α receptor (IFNAR) and therefore cannot respond to type I 
IFNs in general, show immunosuppression after bacterial infection and subsequent adeno-
viral challenge. We infected IFNAR1/2 deficient mice with 5x10
5
 E.coli one day prior to 
AdLOG infection. Cytotoxic activity of CD 8 T cells was measured on day five after ade-
noviral challenge in spleens. 
 
 
Figure 4.23   IFNs were essentially involved in the suppression of antigen-specific CTL re-
sponse by E.coli  
C57BL/6 wild type mice and mice deficient in the IFNAR1 and IFNAR2 (A), IRF7 or IRF3/7 (B) 
were infected with 5x10
5
 E.coli one day before immunization with AdLOG. The activity of OVA-
specific cytotoxic CD 8 T cells was determined five days after adenoviral infection in spleens. Data 
presented as +/- SEM with at least n=3 mice. Representative data are shown of two independent 
experiments. (n.d.=not detectable) 
 
Mice lacking both chains (1 and 2) of the IFNAR showed reduced antigen-specific cyto-
toxicity after pretreatment with E.coli. However compared to wild type mice the CTL re-
sponse was significantly enhanced which proposed involvement of the type I interferon 
signaling pathway in mediating dampening of CTL responses after E.coli stimulus (Figure 
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4.23 A). Furthermore upon binding of IFN to its receptor, the transcription factors IRF3 
and IRF7 are activated and translocate into the nucleus where they exert their function. 
Compared to wild type mice, mice lacking IRF7 as well as mice lacking both IRF3 and 
IRF7 showed an enhanced capability to induce a CTL response (Figure 4.23 B). Thus IRF3 
and IRF7 signaling were both involved in E.coli mediated suppression of antigen-specific 
CTL responses.  Additionally these data suggest that the amplification of the type I interfe-
ron signal via the IFNAR 1 and 2 and IFR 7 is involved in the suppression of CTL res-
ponses in the same manner as the initial induction of type I IFNs. 
4.8 Regulation of adaptive and innate immune responses by TLR 
ligands 
It is known that stimulation of pattern recognition receptors (PRR) on professional antigen 
presenting cells (APC), such as DCs is a prerequisite for the induction of functional adap-
tive immune responses (Blander and Medzhitov, 2006). Upon TLR stimulation DCs alter 
their phenotype from an immature to a mature status, which is characterized by secretion 
of cytokines, up-regulation of MHC molecules and their ability to efficiently prime T cell 
responses (Inaba et al., 1993; Ludewig et al., 1998; Reis e Sousa et al., 1997). Thus it was 
striking that mice deficient in both MyD88 and TRIF signaling and hence lacking complete 
TLR signaling were still able to induce a strong antigen-specific CTL response upon infec-
tion with adenovirus (Figure 4.21 A). First, to determine whether only CTL responses 
against adenovirus were independent of TLR signaling or whether it could be extended to 
other viral infections, we infected MyD88xTRIF deficient mice with other viruses such as 
Influenza virus, mouse cytomegalovirus (MCMV-OVA), or herpes simplex virus type 
1(HSV). Antigen-specific cytotoxic responses were determined in spleens on day five after 
viral infection. Interestingly, also for these viruses TLR signaling was not mandatory for 
the induction of effective antigen-specific CTL responses, as MyD88xTRIF deficient mice 
were able to generate CTL responses as efficient as wild type mice against Influenza virus, 
MCMV and HSV-1 (Figure 4.24) 
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Figure 4.24   MyD88xTRIF deficient mice were able to induce strong CTL responses against 
different viral infections as efficient as wild type mice. 
C57BL/6 wild type mice and mice deficient in both MyD88 and TRIF were infected either with 
1x10
5
 PFU Influenza virus, 2x10
5
 PFU MCMV-OVA or 1x10
4
 PFU HSV i.v.. Five days after im-
munization antigen-specific CTL responses were determined in spleens. Data are presented as 
mean +/- SEM with n=3 mice per group. 
 
Based on these findings we further hypothesized that TLR signaling was not required for 
generation of effective CTL responses in general but instead played a crucial role in mod-
ulating CTL responses. This hypothesis was further supported by the fact that E.coli treat-
ment and TLR4 signaling could dampen or enhance CTL responses whether TLR signaling 
occurred before or after viral infection (Figure 4.6). Despite their ability to induce matura-
tion of DCs and subsequent induction of adaptive immunity, TLR ligands also trigger the 
innate immune system by promoting the release of pro-inflammatory cytokines as well as 
by enhancing phagocytosis of pathogens (Akira, 2006; Akira et al., 2006; Blander and 
Medzhitov, 2004). For example, TLR2 signaling is strongly associated with the release of 
nitric oxide (NO) and stimulation of TLR4 is reported to initiate the release of defensines 
(Lehrer and Ganz, 2002; Thoma-Uszynski et al., 2001). Additionally macrophages are ef-
ficiently activated by TLR ligands. TLR stimulation leads to secretion of pro-inflammatory 
cytokines by macrophages themselves as well as DCs (Akira et al., 2006). 
Therefore, we analyzed the importance of TLR signaling on innate immunity. Wild type 
and MyD88xTRIF deficient mice were infected with a lethal dose of Listeria monocyto-
gens alone or were injected i.v. one day prior to listeriosis with E.coli. Wild type mice that 
had not been infected with E.coli, rapidly died from day four on due to listeriosis (Figure 
4.25 A). In contrast, a previous injection of E.coli rendered mice resistant to a detrimental 
infection with Listeria monocytogenes. This protection required signaling via TLRs, as 
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MyD88xTRIF deficient mice were susceptible to listeriosis irrespective of whether they 
received a previous injection of E.coli or not.  
 
 
Figure 4.25   Mice previously infected with E.coli showed less susceptibility to listeriosis, en-
hanced survival and bacterial clearance in a TLR signaling dependent manner 
Analysis of survival of mice after infection with 5x10
4
 CFU Listeria monocytogenes 
(A) C57BL/6 wild type mice or mice deficient in MyD88 and TRIF were infected with 5x10
5
 
E.coli prior to administration of Listeria or left untreated. (B) C57BL/6 mice were injected with 
20µg ssRNA complexed in DOTAP, 1µ LPS or 50µg pI:C respectively one day prior to infection 
with Listeria. Survival of mice was assayed once a day. Experiment was performed with (A) n=9 
mice per group and (B) n=6 mice per group. 
 
To investigate if the protective effect of E.coli during Listeria infection was restricted to 
bacterial TLR ligands, we treated C57BL/6 wild type mice with different bacterial or viral 
TLR ligands prior to Listeria infection. To this end ssRNA recognized by TLR7 and TLR8, 
LPS which binds to TLR4, and the ligand for TLR3 pI:C were injected i.v. one day before 
infection with a lethal dose of Listeria monocytogenes. All mice that had received TLR 
ligands prior to infection with Listeria were significantly protected and survived the 
infection, whereas all untreated wild type mice died on day four (Figure 4.25 B).  
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Figure 4.26   E.coli pretreatment enhanced capability of macrophages to kill Listeria in vivo 
and ex vivo 
(A) C57BL/6 mice were treated with PBS or 5x10
5
 E.coli one day prior to infection with 1x10
5
  
Listeria. Bacterial load was determined in spleens and livers of mice two and four days after infec-
tion with Listeria and is displayed as CFU per gram tissue. (B) Macrophages were isolated from 
spleen of mice infected with 5x10
5
 E.coli or left untreated. Isolated macrophages were infected in 
vitro with 1x10
5
 Listeria and bacterial burden was determined at indicated time points.  
 
These results clearly showed that application of TLR ligands in general was protective in 
an infection model of Listeria monocytogens. Next we analyzed if the enhanced survival of 
mice pretreated with TLR ligands was due to an increased clearance of bacteria. 
Accordingly, we assessed the bacterial load in spleens and livers after two and four days 
post infection in mice, that had been left untreated or were injected i.v. with UV-killed 
E.coli. Mice that were infected with UV-killed E.coli one day prior to Listeria infection 
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showed improved clearance of Listeria in spleens and livers after two hours (Figure 4.26 
A). In mice treated with PBS no bacterial load could be determined since they died from 
listeriosis on day three and four. To further investigate if the enhanced clearance of Listeria 
was due to an improved activity of macrophages, we isolated splenic macrophages from 
mice treated with UV-killed E.coli or PBS on the day before isolation. Macrophages were 
infected ex vivo with Listeria monocytogenes and CFU per 1x10
6
 cells was determined 
after two and six hours. Macrophages isolated from mice preatreted with E.coli killed 
Listeria much better than macrophages from control mice (Figure 4.26 B). From this 
observation we concluded that triggering of TLR signaling on the one hand could modulate 
CTL responses but at the same time could enhance innate immunity, such as activation of 
macrophages. 
 
4.9 Summary of chapter 4 
Our data presented here showed that high numbers of bacteria rapidly disseminated to dis-
tant organs in a mouse model for sepsis (CASP), whereas sham treatment led to bacterial 
translocation only to a minor extent. Most importantly, mice that underwent CASP showed 
a significant impairment of CTL responses against subsequent infections with viral and 
bacterial pathogens in contrast to sham treated mice which efficiently generated antiviral 
cytotoxic T cell responses. This suppression was characterized by reduced numbers of an-
tigen-specific CD8 T cells which did lacked antigen-specific cytotoxicity and correlated 
with the amount of bacteria that had reached the spleen. Moreover, only CTL responses 
towards subsequent systemic infections were inhibited, whereas the generation of already 
established CTL responses was stimulated and induction of local immunity was unaffected. 
We revealed that Kupffer cells and TNF within the liver contributed to the retention and 
clearance of gut-derived bacteria, thereby preventing systemic distribution of bacteria and 
in consequence immune suppression.  
Furthermore, our data indicated that antigen-specific CTL responses against systemic in-
fections were mainly induced in the spleen and required an intact splenic architecture. Effi-
cient induction of adaptive CD8 T cell responses in the spleen depended on 
CD8+DEC205+ DCs and metallophilic marginal zone macrophages (MMMs). Both DCs 
and MMMs were affected by bacteremia as they were not able to induce CTL responses 
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after exposure to E.coli. We identified TLR4 downstream signaling via TRIF and a subse-
quent expression of type I IFNs to be involved in mediating the suppression of antigen-
specific CTL responses. Furthermore, we revealed that TLR signaling is not necessarily 
required for the initiation of CTL responses, but rather is indispensable for induction of 
innate immune responses. Thus, our results imply a dual role of TLRs, as the anatomical 
site, dose and time point of TLR ligand application determined if a systemic adaptive   
immune response was stimulated or suppressed. 
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5 Discussion 
Sepsis, systemic inflammatory response syndrome (SIRS), and multi-organ failure are se-
rious clinical problems because of high patient morbidity and mortality. One factor thought 
to be important in the etiology of SIRS is a failure of the intestinal barrier resulting in bac-
terial translocation and subsequent bacteremia causing sepsis (Nieuwenhuijzen et al., 
1996a; Pastores et al., 1996). Whereas the influence of sepsis on the innate immune system 
is well described, the counter regulatory mechanisms and the impact on the adaptive im-
mune system are still largely unknown. 
The aim of this thesis was to analyze the influence of gut-derived bacteria on the induction 
of systemic immune responses. Disintegration of the gut barrier led to profound release of 
intestinal bacteria resulting in a rapid systemic dissemination. Here we showed that bacte-
remia caused suppression of adaptive immune responses against subsequent viral and bac-
terial pathogens, which was characterized by reduced numbers of antigen-specific cytotox-
ic T cells and a lack of antigen-specific cytotoxicity. Interestingly, a systemic distribution 
was not always observed upon bacterial translocation from the gut as the liver exhibited a 
filter function thereby preventing the dissemination of gut-derived bacteria, development 
of bacteremia and subsequent immunosuppression. Importantly, the induction of local im-
munity at peripheral sites was not affected by bacteremia, contradicting the current opinion 
of a general, systemic immunosuppression following sepsis. Moreover, bacteremia exclu-
sively suppressed the generation of subsequent adaptive immune responses, whereas al-
ready established CTL responses were further stimulated by systemic bacteria. Although 
E.coli stimulated a broad variety of TLRs, suppression was solely dependent on TLR4 ac-
tivation. Neither TLR4 downstream signaling via MyD88 nor expression of the potent 
suppressive cytokine IL-10 contributed to the observed immunosuppression after bactere-
mia. Instead signaling via TRIF and subsequent expression of type I interferons (IFNs) 
were critically involved in E.coli-mediated CTL suppression. 
Suppression of systemic CTL responses strictly relied on bacteria being present in the 
spleen. We demonstrate here that the induction of adaptive immune responses against sys-
temic infections, such as infection resulting from blood-born adenovirus, was initiated in 
the spleen. Furthermore, macrophages and DCs in the marginal zone were critically in-
volved in the generation of adaptive immunity. It is known that metallophilic marginal 
 Discussion 
73 
 
zone macrophages (MMMs) play an important role in the induction of CTL responses as 
they efficiently take up blood borne antigens and transfer them to cross-presenting DCs 
(Backer et al., 2010). Exposure of these cell types to E.coli impaired their ability to induce 
adaptive immunity to subsequent adenoviral infection thus pointing out the central role of 
splenic macrophages and DCs in the induction of immunosuppression after sepsis.  
The observed suppression of adaptive immunity was striking as pathogens are known to be 
potent activators of the innate immune system by stimulation of pattern-recognition recep-
tors (PPRs) such as Toll-like receptors (TLRs). In addition, activation of the innate im-
mune system is known to be essential for the initiation of an effective adaptive immune 
response (Akira et al., 2006; Iwasaki and Medzhitov, 2004). Here we showed that activa-
tion of innate immunity indeed strictly depended on TLR signaling, whereas such signaling 
was not required for triggering of effective adaptive immune responses. Activation of 
TLRs on the one hand led to effective induction of innate immunity, but on the other hand 
exerted mechanisms which could rather regulate adaptive immune responses in a paracrine 
manner. The results presented in this thesis clearly demonstrate a dual role of TLRs: the 
anatomical site, dose and time point of TLR ligand application determined whether an 
adaptive immune response was stimulated or suppressed.  
5.1 The liver retains translocated bacteria thereby inhibiting spleen-
dependent suppression of adaptive immune responses during sepsis  
The gut is the largest border surface of the body and plays an important role in digestion 
and absorption of nutrients. Overall the intestine harbors > 10
14
 bacteria with at least 
500−1,000 species (Gill et al., 2006; Sonnenburg et al., 2004). Therefore the intestinal epi-
thelium represents a critical barrier between the huge reservoir of endotoxins and the cells 
of the body (Magnotti and Deitch, 2005). Breakdown of this gut barrier leads to transloca-
tion of bacteria and subsequent dissemination to distant organs, such as mesenteric lymph 
nodes, liver, lung and spleen (Caso et al., 2009; Deitch and Berg, 1987b; Deitch et al., 
1986; Schulte-Herbruggen et al., 2009).  
In this study we reported that the integrity of the gut barrier could be disrupted by mechan-
ical stress during abdominal surgery. Abdominal surgery, mimicked by a sham operation, 
resulted in bacterial translocation and bacteria were found predominantly in liver, lung, and 
mesenteric lymph nodes (Figure 4.3). Bacterial translocation was even worse in a common 
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model of poly-microbial sepsis, namely the ascendens stent peritonitis (CASP), in which 
gut content is released through a stent into the peritoneal cavity. In vivo imaging experi-
ments revealed that bacteria disseminated very fast and were detected in comparable num-
bers in all organs after 150 min.  (4.1 A and B). This is in line with clinical observations, 
where perforation of the gut, as observed for example in leaky anastomosis or ruptured 
appendix, subsequently leads to sepsis (Komen et al., 2008).  
We and others have revealed that systemic exposure to TLR ligands suppresses adaptive T 
cell immunity (Mellor et al., 2005; Wingender et al., 2006). Likewise, we investigated if 
bacteria, which have translocated from the gut were also able to inhibit the induction of 
CTL responses. Mice that underwent CASP lacked effective CTL responses (Figure 4.2). 
In contrast, mice that underwent abdominal surgery were not impaired in their ability to 
induce CTL responses upon adenoviral infection, despite of bacteria being present in sev-
eral organs (Figure 4.3 and Figure 4.4). We assume that this difference is due to varying 
amounts of bacteria being present in the spleen. This hypothesis was further substantiated 
by the fact that the degree of suppression strictly correlated with the number of injected 
bacteria (Figure 4.5 B). Mice injected with E.coli i.po., where only few bacteria reached 
the spleen, generated significantly stronger CTL responses compared to mice infected with 
the same amount of bacteria i.v., where high amounts of bacteria were detected in the 
spleen (Figure 4.8 B). These data provide strong evidence that suppression of CTL res-
ponses depends on high numbers of bacteria reaching the spleen while low amounts of 
bacteria do not negatively influence CTL response since they do not reach the spleen. Con-
sidering the differences in bacterial distribution after i.v. and i.po. application of E.coli 
(Figure 4.8 A), these data clearly imply that the liver might play an important role in the 
retention of bacteria. Indeed, it has been described that the liver represents an important 
barrier which trap and clear bacteria as well as endotoxins that translocate from the gut via 
the vascular route and enter the liver through the portal vein (Gregory et al., 2002; Gregory 
et al., 1996; Gregory and Wing, 2002; Jacob et al., 1977). This retention and clearance is 
attributed to resident liver macrophages, namely Kupffer cells, which line the hepatic sinu-
soids and are found in greatest numbers in the periportal area (Fox et al., 1987). In line 
with that we observed that E.coli bioparticles, injected into the portal vein, were efficiently 
taken up by Kupffer cells (Figure 4.9) and that mice were incapable to retain and clear i.po. 
injected bacteria after depletion of Kupffer cells by clodronate liposomes (Figure 4.10). In 
addition, we demonstrated that TNF was critically involved in the clearance and retention 
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of gut-derived bacteria as neutralization of secreted TNF or inhibition of TNF signaling via 
the TNF receptor resulted in an increase of bacterial burden mainly in the liver (Figure 
4.11). As the biological effects of TNF vary from inducing cell death to promoting cell 
regeneration it will be difficult to identify a single effect of TNF on the bacterial clearance 
in the liver (Baker and Reddy, 1998; Leist et al., 1995a; Leist et al., 1995b). One possibili-
ty how TNF mediates its antibacterial effect might be by enhancing the adhesion of neu-
trophils within the liver. TNF has been shown to directly exert the expression of epithelial 
cell-derived neutrophil-activating protein-78 (ENA-78) as well as the integrin α5β1, which 
contribute to adhesion of neutrophils (Keates et al., 1997; Sun et al., 2010; Yoshimura et 
al., 1987). Along this line, neutrophil-Kupffer cell interaction has been described to be 
critically involved in host defense against systemic bacterial infection (Gregory et al., 
1996; Gregory and Wing, 2002). Neutrophils accumulate within the liver sinusoids and kill 
bacteria onsite by the formation of neutrophil extracellular traps (NETs) which are build up 
by rapid release of DNA (Clark et al., 2007; Yousefi et al., 2008). Moreover the interaction 
between Kupffer cells and neutrophils is beneficial as neutrophils synthesize and secrete 
soluble factors that decrease the release of pro-inflammatory cytokines like IL-6 or TNF by 
Kupffer cells (Daley et al., 2005; Holub et al., 2009). Modulating the release of pro-
inflammatory cytokines allows the inflammation to stay local thereby avoiding life-
threatening systemic inflammatory response syndromes with concurrent clearance of bac-
teria within the liver. Future experiments need to be designed in order to analyze the exact 
role of TNF in the clearance of bacteria in the liver. Overall our findings underline the im-
portance of TNF in the clearance of bacteria in the liver and thereby contributes to the 
maintenance of  homeostasis.  
It is discussed that bacterial translocation from the gut is the origin of sepsis and subse-
quent multi organ dysfunction syndrome (MODS) (Nieuwenhuijzen et al., 1996a, b; 
Pastores et al., 1996). In contrast our data suggest that bacterial translocation does not al-
ways lead to sepsis and subsequent MODS. The induction of CTL responses is not inhi-
bited if low amounts of translocating bacteria are trapped and cleared within the liver. 
However, breakdown of this filter function by vast amounts of translocated bacteria or in 
the absence of macrophages or TNF, respectively, results in a systemic dissemination of 
bacteria and subsequent suppression of spleen-dependent CTL responses.  
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5.2 Mechanisms of  E.coli-mediated suppression of adaptive immune 
responses  
In general, stimulation of innate immune system by TLR ligands initiates the generation of   
subsequent adaptive immunity by causing functional maturation of antigen-presenting 
cells. However, we could show that a systemic exposure to E.coli resulted in the suppres-
sion of subsequent adaptive immunity against various viral and bacterial pathogens (Figure 
4.7). This E.coli-mediated suppression was characterized by a reduction in the number of 
antigen-specific T cells that led to lack of specific cytotoxicity (Figure 4.6 B).  These find-
ings are in line with several reports showing that systemic exposure to TLR ligands sup-
presses subsequent adaptive immune responses (Mellor et al., 2005; Wingender et al., 
2006). Interestingly, we observed that the dosage and time point of E.coli infection played 
a crucial role in the determination whether CTL responses against other pathogens were 
stimulated or suppressed. Low doses of E.coli did not influence the induction of CTL res-
ponses against a subsequent adenovirus infection, whereas doses greater than 1x10
4
 E.coli 
significantly reduced CTL responses (Figure 4.5 B). Moreover, the suppressive effect of 
E.coli lasted for about five days, as injection of E.coli seven days before infection with 
adenovirus did not inhibit antigen-specific cytotoxicities (Figure 4.5 A). In contrast, ad-
ministration of E.coli after infection with adenovirus boosted the generation of antigen-
specific CTL responses. Both cytotoxic activity and the numbers of antigen-specific CD8 
T cells were enhanced in mice treated with E.coli after adenoviral infection (Figure 4.6 A 
and B) indicating that systemic bacteria did not negatively influence already induced anti-
gen-specific CTL responses. This finding supports the current opinion postulating immu-
nostimulatory properties of TLR ligands (Akira et al., 2006; Iwasaki and Medzhitov, 
2004). Taken together, we demonstrate that the time point of bacteria being present in the 
spleen determines whether antigen-specific CTL responses are suppressed or even en-
hanced.    
5.2.1 Suppression of adaptive immunity is associated with the spleen and relies on 
TLR4-dependent TRIF signaling  
Next we were interested in analyzing the impact of bacteremia on the induction of local 
immunity. Interestingly, systemic injection of E.coli did not impair the induction of local 
immunity in the lung against adenovirus, whereas CTL responses were absent in the spleen 
after a systemic adenovirus infection. Thus, suppression of CTL responses seems to be a 
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phenomenon affecting systemic immunity, whereas local immunity at peripheral sites is 
not altered. Furthermore, it rules out the importance of the spleen in induction and regula-
tion of adaptive immunity towards systemic infections. 
Based on these findings, the molecular mechanisms underlying the suppression of CTL 
responses by E.coli were unveiled. Cells mainly sense bacteria via TLRs and components 
of E.coli stimulate a broad variety of TLR ligands, such as CpG which is sensed by TLR9, 
peptidoglycan which binds to TLR2 and LPS that stimulates TLR4. TLR4 and its down-
stream signaling pathways play a dominant role in promoting sepsis and solely the block-
ade of TLR4 was shown to protect mice from septic shock (Beutler and Rietschel, 2003; 
Hoshino et al., 1999; Roger et al., 2009). We analyzed the role of TLRs in our model of 
immunosuppression. However, neither TLR9 nor TLR2 contributed to the suppression as 
mice deficient in these TLRs still showed diminished CTL responses upon bacteremia and 
subsequent adenoviral infection. This was unexpected as E.coli provides TLR2 and TLR9 
ligands and systemic application of TLR2 or TLR9 ligands before adenoviral infection was 
shown to potently suppress antigen-specific CTL responses (unpublished findings by Bea-
trix Schumak) (Mellor et al., 2005; Wingender et al., 2006) (Figure 4.19 A and B). Interes-
tingly, suppression by E.coli was solely mediated by TLR4, as mice deficient in TLR4 
were capable to mount strong CTL responses upon infection with E.coli and subsequent 
immunization with adenovirus (Figure 4.19 C). Although CD14 is known to be critically 
involved in recognition of LPS (Kitchens and Thompson, 2005) it did not significantly 
contribute to suppression by E.coli (Figure 4.20). The role of CD14 and its interaction with 
TLR4 and the myeloid differentiation factor 2 (MD-2) is controversially discussed in lite-
rature. While observations by Jiang et al. showed that CD14-independent binding of LPS is 
restricted to so called “rough” LPS, recent publications have shown evidence of direct inte-
raction of LPS with MD-2 (Jiang et al., 2005; Park et al., 2009). Furthermore, the publica-
tion of Jiang et al. claimed that CD14 is a prerequisite for TRIF signaling after stimulation 
of TLR4 by LPS. These findings contradict our observation that immunosuppression after 
bacteremia was CD14 independent, but strictly depended on TLR4 and TRIF signaling. To 
further elucidate the role of CD14 or MD-2 in the observed immunosuppression, CD14 
deficient mice will be treated with various types of LPS in future experiments. 
Based on these key findings we investigated the influence of TLR4 induced expression of 
IL-10 in suppression of adaptive immune responses. Stimulation of TLR4 and subsequent 
activation of NFκB leads to the expression of pro- as well as anti-inflammatory cytokines 
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(Boonstra et al., 2006; Hacker et al., 2006). IL-10 is one of the most potent anti-
inflammatory cytokines released by broad variety of immune cells upon stimulation with 
pathogen-associated molecular pattern (PAMP) and primarily targets antigen-presenting 
cells (Pestka et al., 2004a; Siewe et al., 2006; Zhang et al., 2009). Using IL-10 transgenic 
reporter mice, we revealed that IL-10 was produced mainly by splenic CD11b positive 
cells upon E.coli injection (Figure 4.17). This is in line with findings demonstrating that 
optimal LPS-induced IL-10 production by macrophages require the induction of TLR de-
pendent signaling pathways as well as the production of type I IFNs (Boonstra et al., 2006; 
Chang et al., 2007). Although IL-10 has a strong capacity to inhibit adaptive T cell res-
ponses (Moore et al., 2001), it was not involved in the bacteremia-mediated suppression of 
adaptive immune responses in our model, as mice deficient in IL-10 were still impaired in 
their ability to generate strong CTL responses after E.coli treatment (Figure 4.18). IL-10 is 
produced as part of the homeostatic response to infection and inflammation thus playing a 
critical role in limiting the duration and intensity of immune reactions. As IL-10 did not 
contribute to E.coli-mediated immunosuppression this indicates that the relevant mechan-
isms allowing the development of T cell immunity in the spleen are not influenced by IL-
10 in general.  
5.2.2 E.coli-mediated suppression of CTL responses requires TRIF and type I 
interferon signaling  
Based on these key findings we investigated the relevance of TLR4 downstream signaling 
in suppression of adaptive immune responses. TLR4 signals via two adaptor molecules 
MyD88 and TRIF. While signaling via MyD88 initiates the expression of pro- as well as   
anti-inflammatory cytokines, activation of TRIF predominantly leads to recruitment of 
transcriptions factors, namely IRFs, which induce the expression of type I IFNs (Boonstra 
et al., 2006; Hacker et al., 2006). In accordance with our findings that the absence of TLR4 
prevented immunosuppression, mice deficient in both adaptor molecules MyD88 and TRIF 
showed no E.coli-mediated suppression of adenovirus-specific CTL responses (Figure 
4.21). This result further confirmed the general role of TLR4 in the suppression of CTL 
responses after systemic application of E.coli (Figure 4.21 A). Furthermore, MyD88 did 
not contribute to the suppressive effect of E.coli whereas inhibition of TRIF signaling pre-
vented the induction of mechanisms leading to suppression of CTL responses toward ade-
novirus after systemic exposure to E.coli (Figure 4.21 B and C). TRIF is identified as a 
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regulator of IFN transcription by recruiting IRF3 and IRF7 (Fitzgerald et al., 2003b). In 
line with the literature we could show that type I IFNs were expressed after i.v. injection of 
E.coli and cells in the spleen responded to these cytokines (Figure 4.22) (Decker et al., 
2005). Along this line, we demonstrated that type I IFNs were critically involved in E.coli-
mediated immunosuppression, as mice lacking the IFN-α receptor (IFNAR) as well as 
mice deficient in IRF7 or IRF7 and IRF3 generated significantly enhanced CTL responses 
after bacteremia and subsequent adenoviral infection compared to wild type mice (Figure 
4.23). These data imply an equivalent contribution on immunosuppression of early ex-
pressed type I interferons initiated by IRF3 on the one side and the production of IFNs in-
duced by the amplification loop which is triggered by IRF7 on the other side. This is asto-
nishing because type I IFNs are generally associated with immune stimulation, as type I 
IFNs are known to enhance DC maturation and activation as well as differentiation of CD8 
T cells by providing signal 3 (Curtsinger et al., 2005; Le Bon et al., 2003; Luft et al., 1998; 
Montoya et al., 2002). Thus, type I IFNs display an essential link between early innate and 
subsequent adaptive immune responses (Biron, 2001; Bogdan et al., 2004). In contrast to 
the stimulatory capacity, also anti-inflammatory functions of type I IFNs have been re-
ported in several models of autoimmunity such as colitis or systemic lupus erythematosus 
(Hron and Peng, 2004; Katakura et al., 2005). Furthermore, effector T cells, macrophages, 
as well as DCs are sensitized to apoptosis upon exposure to type I FNs (Lehner et al., 
2001; Merrick et al., 1997; Stockinger et al., 2002). In addition, it has been reported that 
these double sided effects of type I IFNs apply to alterations in antigen cross-presentation 
of DCs depending on their maturation. Exposure of mature DCs to type I IFNs results in 
upregulation of co-stimulatory molecules such as CD40L or IL-12 (Gautier et al., 2005; 
Luft et al., 1998). In contrast, immature conventional DCs activate STAT1 in response to 
type IFNs which results in significant inhibition of these co-stimulatory molecules, thus 
accounting for the inhibition of CD8 T cell activation (Longman et al., 2007).  
Thus based on our findings that blockade of type I IFNs expression and signaling pre-
vented immunosuppression, type I IFNs are a potential candidate to affect splenic macro-
phages or DCs in our model. To further elucidate the role of type I IFNs in suppression of 
CTL responses after bacteremia, experiments in mice with Cre-mediated cell type-specific 
IFNAR deficiency need to be performed.  
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5.3 The crosstalk of splenic macrophages and DCs is crucial for 
induction and suppression of CTL responses 
Since the spleen as a secondary lymphoid organ is known to be critically involved in the 
induction of CTL responses we investigated the role of the spleen in our model of adeno-
viral infection (Backer et al., 2010; Balazs et al., 2002; Mebius and Kraal, 2005; Oehen et 
al., 2002). After splenectomy mice were not able to induce adenovirus-specific CTL res-
ponses any more. The ability to mount a CTL response upon adenoviral infection could 
partially be restored by re-transplantation of the spleen into splenectomized mice (Figure 
4.13) This clearly reveals that the spleen is required for effective induction of systemic 
immunity against adenoviral infections. Importantly, we demonstrated that reconstitution 
of splenectomized mice with splenic single cell suspensions failed to rescue the ability to 
induce CTL responses. Thus, the lack of CTL responses is not due to the absence of splen-
ic cells but rather the consequence of a lack of particular compartments within the spleen 
that promote development of T cell immunity.  
In collaboration with the group of Joke de Haan we have recently shown that macrophages 
in the marginal zone efficiently take up blood borne antigens and transfer them to CD8+ 
splenic DCs, leading to an efficient cross-presentation and priming of CTL responses 
(Backer et al., 2010). Moreover, DCs present in the marginal zone play an essential role in 
priming CTL responses (Belz et al., 2005; de Haan et al., 2000). Based on these findings 
we analyzed the role of marginal metallophilic macrophages (MMMs) and CD8+ splenic 
DCs in the induction of adenovirus-specific immune responses. Depletion experiments 
revealed that both MMMs and DCs are essential for an effective CTL response upon ade-
noviral infection (Figure 4.14). Interestingly, DCs alone were not efficient to induce CTL 
responses. As there is a close collaboration between macrophages and DCs in the marginal 
zone of the spleen we further analyzed the impact of E.coli on these two cell populations. 
Histological analysis revealed that adenovirus predominantly infected MMMs (Backer et 
al., 2010; Qiu et al., 2009)and macrophages in the marginal zone efficiently phagocytosed 
E.coli (Figure 4.15). To circumvent the need of macrophages in the induction of CTL res-
ponses we immunized mice with an OVA-coupled antibody (DEC205-OVA), which di-
rectly targeted the antigen to CD8+ DCs. Depletion of macrophages with clodronate lipo-
somes and subsequent immunization of mice with DEC205-OVA led to a strong CTL re-
sponse (Backer et al., 2010). Nevertheless, CTL responses were significantly reduced in 
mice pretreated with E.coli and subsequent DEC205-OVA immunization. The same out-
 Discussion 
81 
 
come was observed if the antigen was directed to MMM by Siglec-1-OVA antibody (Fig-
ure 4.16). As in both cases CTL responses were suppressed after systemic E.coli we con-
clude that both macrophages as well as DCs are affected by exposure to E.coli. So far, we 
were not able to determine whether macrophages release mediators upon E.coli stimulation 
which subsequently suppresses the DCs or if macrophages themselves lack their ability to 
hand over antigen to the DCs. For this reason it would be interesting to analyze the ability 
of mice depleted of macrophages to induce CTL responses after bacteremia and immuniza-
tion with DEC205-OVA. This experiment could be performed in transgenic mice express-
ing the diphtheria toxin receptor under the CD11b promoter or by depletion of macrophag-
es by clodronate liposome application. Alternatively cell-type specific TLR4 deficient 
mice could be used to reveal the cell type which is initially responsible for the induction of 
suppression.  
Furthermore we observed that reduced numbers of DCs were present in the marginal zone 
after exposure to E.coli compared to untreated mice (Figure 4.15). On one hand this could 
be due to depletion of DCs by apoptosis or, on the other hand due to DC-migration from 
the marginal zone into the T cell zone of the spleen after exposure to TLR ligands (De 
Smedt et al., 1996; Hotchkiss et al., 2002; Wen et al., 2008). In the latter case DCs would 
not be able to gain the antigen from macrophages located in the marginal zone due to spa-
tial separation. Although we cannot exclude depletion of DCs so far we have preliminary 
data underlining the theory that DCs migrate and could not reach the antigen. 
The late phase of sepsis is characterized by immune suppression (Docke et al., 1997; 
Heidecke et al., 1999)  caused by profound depletion of immune effector cells (Hotchkiss 
and Karl, 2003; Hotchkiss et al., 2003; Hotchkiss et al., 2001). Here we report that immu-
nosuppression in sepsis is not exclusively due to a profound depletion of lymphocytes and 
secretion of anti-inflammatory cytokines but rather due to a failure of spleen-resident ma-
crophages and DC to induce CTL responses.  
5.4 TLR-signaling determines the outcome of CTL responses  
DCs constitutively sample their microenvironment and phagocytose pathogens as well as 
host apoptotic cells (Greenberg and Grinstein, 2002; Ravichandran, 2003; Savill et al., 
2002).The induction of functional adaptive immune responses requires the activation of 
professional antigen presenting cells, such as DCs (Blander and Medzhitov, 2006). Upon 
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TLR stimulation DCs alter their phenotype from an immature to a mature phenotype, 
which is characterized by secretion of cytokines, up-regulation of MHC molecules and 
their ability to efficiently prime T cell responses (Inaba et al., 1993; Ludewig et al., 1998; 
Reis e Sousa et al., 1997). In vivo, two major receptor families play prominent roles: TLRs 
and tumor necrosis factor (TNF) receptors, mainly CD40 (De Smedt et al., 1996; Hawiger 
et al., 2001; Sparwasser et al., 2000). Without this stimulation, DCs differentiate into a 
tolerogenic phenotype and induce tolerant or regulatory T cells (Steinman et al., 2003). 
Therefore efficient induction of CTL responses strictly correlates with close association of 
antigen and TLR ligands in one cellular compartment  as CTL activity was increased, if 
antigens were coupled to TLR-L directly (Blander and Medzhitov, 2006; Heit et al., 2007). 
In contrast to these studies, our findings revealed that TLR signaling through MyD88 and 
TRIF is not required for efficient induction of CTL responses. Mice lacking entire MyD88 
and TRIF still induced profound antigen-specific CTL responses upon infection with a 
broad variety of viral infections such as adenovirus, influenza virus, MCMV, and HSV 
(Figure 4.21 A and 4.24). This finding was not completely unexpected, as virus can be 
recognized by the inflammasome or intracellular PRRs such as RIG-I or MDA5 which 
subsequently leads to activation and maturation of DCs (Franchi et al., 2010; Kato et al., 
2006; Yoneyama et al., 2004). Based on these findings, we hypothesize that TLR signaling 
is not required for generation of effective CTL responses in general but instead plays a 
crucial role in modulating CTL immunity. This hypothesis was further supported by the 
fact that E.coli treatment and TLR4 signaling could dampen or enhance CTL responses, 
depending on whether TLR signaling was initiated before or after viral infection (Figure 
4.6).  
TLR ligands do not solely induce maturation of DCs and thus promote adaptive immunity, 
but they are also able to prime the innate immune system as well. For example, TLR2 sig-
naling is strongly associated with the release of nitric oxide (NO) and stimulation of TLR4 
is reported to initiate the release of defensines (Lehrer and Ganz, 2002; Thoma-Uszynski et 
al., 2001). Additionally, macrophages are efficiently activated by TLR ligands and TLR 
stimulation leads to secretion of pro-inflammatory cytokines by macrophages themselves 
as well as DCs (Akira et al., 2006). Accordingly, we demonstrated that mice treated with 
E.coli i.v. and subsequently infected with Listeria monocytogenes survive listeriosis, whe-
reas mice that had not been infected with E.coli rapidly died due to listeriosis (Figure 4.25 
A). Importantly, this protective effect was dependent on TLR signaling as mice deficient in 
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MyD88 and TRIF were not protected from listeriosis irrespective of whether they had been 
previously infected with E.coli or not. Moreover, the protective effect was not restricted to 
E.coli as previous application of TLR ligands to infection with Listeria was shown to pro-
tect mice from listeriosis (Figure 4.25 B). The improved survival was due to significantly 
enhanced bacterial clearance in mice pretreated with E.coli as these mice showed reduced 
bacterial burden in spleen and liver compared to untreated mice. In addition, we could as-
cribe the improved bacterial clearance to macrophages as they showed an enhanced ability 
to kill Listeria ex vivo (Figure 4.26).  
These data clearly reveal a new function of TLRs in the induction and regulation of adap-
tive immunity. Although systemic distribution of TLR ligands has no effect on the induc-
tion of local immunity, they exert regulating effects on the induction of CTL systemic im-
mune responses. As expected, triggering of TLRs stimulates the innate immune system, 
but in contrast, systemic TLR ligands inhibit the induction of subsequent CTL responses 
while they boost already established immunity. The group of Reis e Sousa showed that 
APCs cannot be activated in a paracrine manner by cytokines and only direct activation by 
TLRs enable APCs to potently induce immunity (Sporri and Reis e Sousa, 2005). Here we 
showed that the induction of immunity did not depend on TLR signaling but could also be 
triggered by a so far unknown mechanism. Furthermore we could demonstrate that inhibi-
tion of T cell immunity is mediated in a paracrine fashion by type I IFNs. Moreover, these 
data revealed that the molecular mechanisms determining suppression are dominant over 
the induction of immunity.  
Regarding the benefits for the organism we speculate that the observed immunosuppres-
sion represents somehow an “emergency shutdown” of the adaptive immune system to 
prevent autoimmunity. As DCs are known to present self-antigens, this mechanism might 
ensure that the induction of CTL responses only takes place if antigen and stimulation by 
TLRs are present simultaneously, namely if antigen and TLR ligands originate from one 
and the same pathogen. Separation of antigen and TLR stimuli in time would imply that 
antigen and TLR ligands are derived from different sources, therefore increasing the risk of 
stimulating autoimmune responses. Increased cell death occurs in many situations such as 
during sepsis (Hotchkiss et al., 2003; Hotchkiss et al., 2001; Tinsley et al., 2003) and it 
promotes allocation of self antigens such as DNA, heat shock proteins, or high mobility 
group box 1 protein (HMGB1) a nuclear protein that is released passively after lose of cell 
membrane integrity in necrotic cells (Bianchi and Manfredi, 2007; Hof et al., 2005). 
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HMGB1 is taken up and cross-presented on DCs thus giving rise to the production of auto-
antibodies which can be found in a high proportion of patients with various autoimmune 
disorders (Bondanza et al., 2004; Gauley and Pisetsky, 2009; Sobajima et al., 1998; Uesugi 
et al., 1998). Thus, we suggest that TLR-dependent induction of immunosuppression 
represents one of the physiological mechanisms to prevent potentially undesired or even 
harmful immune responses. 
5.5 Conclusion and outlook 
The findings presented in this thesis demonstrate several aspects of immunosuppression 
due to bacteremia. We could show that bacterial translocation per se is not harmful as the 
liver prevents systemic dissemination of gut-derived bacteria. Nevertheless, if bacteria 
reach the spleen, splenic macrophages and DCs are affected in their ability to induce CTL 
responses. Although we revealed that suppression in gram-negative sepsis depends on 
TLR4 signaling via TRIF and subsequent expression of type I interferon, further experi-
ments have to be performed addressing the question which cell type is affected. Further-
more, it remains to be determined whether phenotypical changes of DCs or macrophages 
lead to immunosuppression.  
Nevertheless, profound immunosuppression is a critical factor in intensive care medicine 
as it gives rise to opportunistic infections (Munoz et al., 1991; Mustard et al., 1991; 
Richardson et al., 1982). Therefore, it would be reasonable to prevent the suppression of 
CTL responses due to bacteremia. With respect to our data this would only make sense if 
given in advance to surgery of the gastrointestinal tract. Thus prophylactic pharmacologi-
cal inhibition of TLR4, for example by the drug Eritoran, would prevent sepsis (Wittebole 
et al., 2010) and subsequent immunosuppression.    
Overall these results revealed a dual role of TLRs in the induction of immunity as that the 
anatomical site, dose and time point of TLR ligand application determined if an adaptive 
immune response was stimulated or suppressed. Moreover, these results may provide in-
sights for the development of new therapeutic approaches that might circumvent suppres-
sion of systemic adaptive immune response in septic patients.  
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APC antigen presenting cell 
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CpG cytosine-phosphate-guanosine 
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DC dendritic cell 
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ENA-78 epithelial cell-derived neutrophil-activating protein-78 
ER endoplasmatic reticulum 
FACS fluorescence activated cell sorting 
FCS fetal calf serum 
  
g gram 
g gravity 
GFP green fluorescent protein 
  
h hours 
HMGB1 high mobility group box 1 protein 
HSP heat shock protein 
HSV Herpes Simplex Virus 
  
i.p. intraperitoneally 
i.po. intraportally 
i.v. intravenously 
IFN interferon 
IFNAR type I interferon receptor 
Ig immunoglobulin 
IL interleukin 
IRF interferon regulatory factor 
IRFBS IRF-binding site 
ISGF interferon-stimulated gene factor 
ISRE interferon-stimulates response element 
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JAK Janus kinase 
  
ko knock out 
  
l liter 
Lm Listeria monocytogenes 
LPS lipopolysaccharide 
Lux LuxABCDE genecluster   
 
mM millimolar 
MAPK mitogen-activated protein kinase 
MCMV murine cytomegalovirus 
MDA-5 melanoma differentiation-associated gene 5 
MHC major histocompatibility complex 
min minutes 
ml milliliter 
mm millimeter 
MODS multi organ dysfunction syndrom 
MxA myxovirus resistance protein 
  
NET neutrophils extracellular traps 
ng nanogram 
NK cells natural killer cells 
NOD nucleotide-binding oligomerization domain 
nt nucleotides 
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OD optical density 
ODN oligonucleotide 
ORN oligoribonucleotide 
OVA ovalbumin 
  
PALS periarteriolar lymphoid sheaths 
PAMP pathogen associated molecular pattern 
PBS phosphate buffered saline 
PFA paraformaldehyde 
PFU plaque forming unit 
POI postoperative ileus 
PRR pattern recognition receptor 
  
RIG-I retinoic acid-inducible gene I 
RNA ribonucleic acid 
rpm rounds per minute 
  
s.c.  subcutaneously 
S8L SIINFEKL 
SEM standard error of the mean 
Siglec-1 sialic acid-binding immunoglobulin-like lectin-1 
siRNA small interfering RNA 
ssRNA single-stranded RNA 
SIRS systemic inflammatory response sysndrom 
STAT signal transducers and activators of transcription  
TCR T cell receptor 
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TGF transforming growth factor beta 
Th1 T helper 1 cells 
Th2 T helper 2 cells 
TIR Toll/IL-1 receptor 
TLR Toll-like receptor 
TNF tumor necrosis factor 
TNFR tumor necrosis factor receptor 
Tyk tyrosine kinase 
  
UV ultra violet 
  
v Volume 
VP  virus particles 
  
w weight 
  
YFP yellow fluorescence protein 
  
µg microgram 
µl microliter 
µm Micrometer 
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